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CHAPTER I 
INTRODUCTION 
 
1.1 Introduction 
The previous reports about adult stem cell multipotency have generated 
tremendous interest regarding their potential therapeutic value, while bypassing 
ethical concerns surrounding the use of human embryonic stem cells (Reiser et al., 
2005). Among the different adult stem cells, the bone marrow derived mesenchymal 
stem cells (BM-MSCs) may represent the best hope for cell replacement therapy, in 
addition to their multipotency and accessibility, BM-MSCs may also be used in 
autologous transplantation to minimize immune rejection (Scolding et al., 2008). 
Along with human BM-MSCs, the better characterized cultures are those of rat (Santa 
Maria et al. 2004) and mouse (Baddoo et al., 2003) origin, although therapeutic 
potential in large animal models had been investigated with BM-MSCs from horse 
(Ringe et al., 2003), cow (Bosnakovski et al., 2005), pig (Moscoso et al., 2005), dog 
(Silva et al., 2005), sheep (Rhodes et al., 2004) and baboon (Devine et al., 2001). For 
BM-MSCs’ clinical applications, an adequate number of cells are necessary, and 
considering the low number of BM-MSCs, an extensive in vitro expansion is required 
in order to maintain BM-MSCs’ morphology, biological and functional property 
(Wexler et al., 2003; Caplan, 2007; Neuhuber at al., 2008; Pal et al., 2009). The 
harvesting and expansion methods used by different laboratories are relatively 
standard, BM-MSCs culturing protocols vary widely. Initial densities, level of 
confluence at passage and harvest, and time in culture are factors with unclear impact 
on therapeutic efficacy (Neuhuber et al., 2008).  
Liver transplantation is the primary treatment for various end-stage hepatic 
diseases but is hindered by the lack of donor organs and by complications associated 
with rejection and immunosuppression. The establishment of stem cell therapy for the 
liver is of great significance. There is increasing evidence to suggest the bone marrow 
derived MSC is a transplantable source of hepatocyte in vivo and in vitro (Schwartz et 
al., 2002; Anjos-Afonso et al. 2004; Lee et al. 2004; Wang et al. 2004; Sato et al. 2005; 
Aurich et al. 2007; Kuo et al., 2008). Until now, several models for in vitro hepatocyte 
differentiation are available. These models include addition of soluble medium factors 
(Growth Factors/Cytokines/Corticosteroids/Hormones), reconstruction of in vivo cell-
matrix and cell-cell interactions, determination of cell fate via genetic modification 
(Snykers et al., 2009). However, the degree of differentiation obtained in these models 
is incomplete, and they still demand additional characterization and optimization. 
Recently, the point of interest is the role of epigenetic modifiers in mediating hepatic-
conditioned postnatal progenitor cells toward fully functional hepatocytes. This 
process is still young, critical factors of this process are needed to be studied. Both in 
vivo and in vitro of hepatic differentiation need to be carefully studied in greater depth. 
Fourier transform infrared (FTIR) microspectroscopy has been introduced 
into various biological fields and found to be a very useful tool, particularly for the 
identification of cellular phenotype. Many research works in medical sciences have 
shown the successful use of this technique to characterize various types of cells and 
tissues. For example, cervical cancer (Wood et al., 2004), oral cancer (Schultz et al., 
1998) as well as stem cell differentiation state (Ami et al., 2008; Krafft et al., 2007; 
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Heraud et al., 2010; Tanthanuch et al., 2010) are amenable to characterization by 
FTIR microspectroscopy as it offers the possibility to overcome all problems 
regarding the detection of macromolecular content of whole cell. The current 
information about using FTIR microspectroscopy to study stem cell is still limited and 
to use FTIR microspectroscopy to monitor the differentiation of stem cell in vitro and 
in vivo will give us promising information on stem cell therapy. 
In an attempt to clarify these issues, the aim of this study is to optimize rBM-
MSCs culture system and investigate their hepatic differentiation in vitro and in vivo, 
which will be determined based on conventional characterization method and FTIR 
microspectroscopy. 
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CHAPTER II 
REVIEW OF LITERATURES 
 
2.1 Liver disease 
Liver disease (also called hepatic disease) is a broad term describing any 
single number of diseases affecting the liver. They are caused by infectious agents 
(Soemohardjo, 2003), autoimmune attack (Strassburg et al., 2003), malignant 
transformation (Zhu, 2003), inborn genetic deficiencies (Ballas et al., 2002), or 
secondary defects (Gill and sterling, 2001). Most liver diseases lead to hepatocyte 
dysfunction with the possibility of eventual organ failure. Liver transplantation is 
currently the major therapeutic option for patients with acute and chronic end-stage 
liver disease. However, a shortage of suitable donor organs and a requirement for 
immunosuppressive therapy restrict its usage, highlighting the importance of finding 
suitable alternatives. Furthermore, liver transplantation comes with considerable long 
term side effects, such as chronic renal failure, post-transplantation lympho 
proliferative disorder and cardiovascular complications (Chung et al., 2007; Francoz 
et al., 2007; Patel et al. 2007; Tamsel et al., 2007). The emerging field of stem cell 
therapy has raised great hope for improving the treatment of liver diseases, as it has 
the potential to promote liver repair and regeneration with fewer complications. 
 
 
2.2 Regenerative medicine and stem cell therapy 
Regenerative medicine is the process of creating living, functional tissues to 
repair or replace tissue or organ function lost due to damage, or congenital defects 
(Mason and Dunnill, 2008). It includes both the regeneration of tissues in vitro for 
subsequent in vivo implantation, as well as regeneration directly in vivo by 
engineering the basic building blocks of the human body. It has been proposed that 
regenerative medicine is an amalgamation of a multitude of disciplines including cell 
biology, tissue engineering, biomaterials science, endocrinology and transplantation 
science. If realized, it offers the prospect of extending healthy life span and improving 
the quality of life by supporting and activating the body’s own natural healing. Recent 
interest in stem cell biology and novel biomaterial have raised hopes that 
manipulation and delivery of patient compatible cells and tissues could recapitulate 
the regenerative process and lead to more functional responses to injury (Gurtner et al., 
2007). 
Stem cell refers to a diverse group of unprogrammed cells which are capable 
of self-renewal and retain the plasticity to differentiate into various tissues. Their 
potency largely varies, ranging from pluripotency, the capacity to differentiate to cells 
from any of the three germ layers, to unipotency, the ability to produce only one cell 
type (Fig. 2.1). Stem cells can be divided into two major classes: one is embryonic 
stem cells (ES cells) which derived from the inner cell mass of a blastocyst or morula 
stage embryos and exhibit pluripotency, the other is adult stem cells (AS cells) which 
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are found in most tissues of the adult body, but possess a limited capacity to 
differentiate into various cell types. It is hoped that stem cell-based therapies will help 
people who have and are suffering from devastating disease. The use of stem cells has 
been featured in several untreatable conditions, such as spinal cord injury, heart 
disease and liver disease (Patel and Genovese, 2007; Barnabe-Heider and Frisen, 
2008; Ucceli, 2008; Gordon et al., 2006; Mohamadnejad et al., 2007a). Apart from 
safety and ethical concerns, one of the most particular aspects of ES cell therapy for 
liver disease is the question of whether the cells are really differentiated as desired, so, 
there have been many clinical trials for stem cell therapy of liver diseases by using 
adult stem cell especially bone marrow derived stem cells (Terai et al., 2006; Gaia et 
al., 2006; Gupta et al., 2007; Mohamednejad et al., 2007a; Mohamadnejad et al., 
2007b; Lyra et al., 2007). Recently, the emergencies of induced pluripotent stem cells 
(iPS), which are derived from adult somatic cells (e.g., skin fibroblasts) by their 
infection with retroviruses carrying factors that are important in maintaining the 
“stemness” of ES cell, giving the promising tool for stem cells therapy (Takahashi et 
al., 2007; Park et al., 2008). However, this type of cell is at an early stage which 
means that more research is needed to be done. Although adult stem cells may be 
proven to be useful to improve liver functionality and extend the length and quality of 
life, the difficulty in evaluating mechanisms in human studies poses some questions in 
identifying the best method for various cases in the future. 
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 Figure 2.1  Hierarchy of stem cells. Stem cells can be totipotent (they are produced 
by the fusion of an egg and sperm), pluripotent (they are totipotent cells’ 
descendants) and unipotent (can make only one cell type). 
(www.patentbaristas.com/archives/2008/03/03/ding-warf-wins-round-2- 
as-stem-cell-patent-upheld) 
2.3 Mesenchymal stem cells (MSCs) 
The concept of MSCs arose from the work of Friedenstein and colleagues 
four decades ago (Friedenstein et al., 1976), which are commonly isolated by 
adherence to plastic and consecutive passages in tissue culture after acquiring a 
homogeneous fibroblast-like appearance. MSCs are the non-haematopoietic cell 
component of the bone marrow stroma which is capable of generating the cells of 
mesenchymal lineages, including bone, cartilage, adipose, tendon and muscle tissue 
(Fig 2.2). The in vivo existence of MSCs is supported by the fact that the tissue 
remodeling process during development and throughout postnatal growth, repair and 
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regeneration requires a continuous supply of new cells suggesting the subsistence of 
these cells (Caplan and Bruder, 2001; Baksh et al. 2004). 
 
Figure 2.2  Heamatopoietic and stromal cell differentiation. It shows that bone 
marrow as a reservoir for two distinct developmental systems: the 
heamatopoietic system and the marrow stromal network. The 
heamatopoietic system gives rise to blood cell phenotype and the stromal 
cell network comprises a mixed cell population that generates bone, 
cartilage, fat, fibrous connective tissue and the reticular network that 
supports blood cell formation. 
(www.chroma.med.mimi.edu/micro/faculty-jurecic.html) 
2.3.1 Sources of Primary MSCs 
        MSCs are typically isolated from the stromal fraction of adult bone marrow 
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and are rare in bone marrow, representing only 0.01-0.0001% of nucleated cells 
(Dazzi et al., 2006; Sakaguchi et al., 2005). Normally, murine MSCs are obtained 
from the femurs and tibias of mice by flushing the marrow out of the bones with 
culture medium and transferring the resultant cell suspension in culture (Friedenstein 
et al., 1976). Human MSCs can be similarly obtained from healthy volunteers by 
taking aspirates of bone marrow from the iliac crest and expanding on tissue-culture 
plastic (Risbud et al., 2006). At present, MSCs can be isolated from bone marrow 
(BM; Jiang et al., 2002), adipose tissue (Zuk et al., 2001), dental pulp (Gronthos et al., 
2002), placenta (Yen et al., 2005), umbilical cord blood (UCB; Lee et al., 2004b), and 
from a variety of fetal tissues, such as spleen, lung, pancreas, kidney and amniotic 
fluid during mid-gestation (De Coppi et al., 2007). Amniotic fluid has also been cited 
as a source of MSCs, with potential far-reaching implications for such areas as 
prenatal diagnosis and gene therapy (Pieternella et al., 2003). 
2.3.2 Isolation of primary MSCs 
Mesenchymal stem cells have been isolated from human and a number of 
other species, such as rat (Santa Maria et al., 2004), mouse (Baddoo et al., 2003), 
horse (Ringe et al., 2003), cow (Bosnakovski et al., 2005), pig (Moscoso et al., 2005), 
dog (Silva et al., 2005), sheep (Rhodes et al., 2004) and baboon (Devine et al., 2001). 
Three main approaches have been described for the isolation of MSCs and can either 
be used independently or combined together to obtain a more homogeneous culture. 
The traditional isolation method relies on the fact that MSCs selectively adhere to 
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plastic surfaces, whereas hematopoietic cells do not and can therefore be removed 
through medium changes (Luria et al., 1971). While this eliminates most 
contaminating cells, the remaining heterogeneity of the culture progressively 
decreases by serial passaging and after a number of passages the culture is enriched in 
the self-renewing fraction, the stem cells. Another published isolation protocol 
involves centrifugation over a Percoll gradient, which separates cell populations based 
on their density and allows the enrichment of nucleated cells (Dazzi et al., 2006). 
However, both methods are quite nonspecific and an approach that is now 
increasingly being used, resorts to sorting of bone marrow populations by flow 
cytometry (FACS), based on MSC reactivity to a number of antibodies. This can 
either be achieved by positively selecting for expressed antigens or by a process of 
immunodepletion of cells expressing hematopoietic and/or other lineage antigens. For 
instance, antibodies against CD34, a surface marker found on hematopoietic cells, are 
frequently used to identify and remove nonmesenchymal cells from a marrow culture 
(Pittenger et al., 1999). Since there is no single specific marker available to 
unequivocally identify the MSC, different groups have opted for a variety of marker 
combinations. MSCs appear relatively stable as primary cultures (Mareschi et al., 
2006; Bernardo et al., 2007), although spontaneous transformation events have been 
observed in long-term cultures (De la Fuente et al., 2010).  
2.3.3 In vitro characteristics of MSCs 
The identification of MSCs remains elusive (Dominici et al., 2006) and 
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relies upon the ability of the cells to differentiate in vitro into multiple lineages and 
the expression of CD13, CD29, CD31, CD44, CD54, CD63, CD73, CD 90, CD105, 
CD106, CD140b, CD166, Stro1 as well as the absence of heamatopoietic markers 
(Pittenger et al., 1999; Colter et al., 2000). Comparisons of the various combinations 
used by different investigators show that the majority of subsets include either CD29, 
CD105 or both. Although these markers have been used by various groups, there is 
still no general consensus on the optimal marker combination for MSCs. In the 
absence of a specific cell marker, MSCs may well incorporate a number of different 
cell populations all potentially variable in their phenotypic and growth characteristics, 
with mesenchymal differentiation as a common denominator. 
2.3.4 Self-renewing potential of MSCs 
One of the defining characteristics of stem cells is their self-renewal 
potential, the ability to generate identical copies of themselves through mitotic 
division over extended periods (Gronthos et al., 2003). It has been proposed that stem 
cells are in an in vivo resting state and only divide when a stimulus is provided by 
neighboring cells in the microenvironments (Wilson and Trumpp, 2006; Moore and 
Lemischka, 2006). Depending on the stimulus, cells are known to undergo either 
symmetric or asymmetric division, thus the stem cell pool is kept constant but may 
expand in case of an injury or damage (Satija et al., 2007). 
As a population, bone marrow derived MSCs have been demonstrated to 
have a significant but highly variable self-renewal potential during in vitro serial 
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propagation (Colter et al., 2000). Their entry into the cell cycle and subsequent 
development into colonies depend on serum growth factors, such as basic fibroblast 
growth factor-2 (FGF-2) which have been demonstrated to maintain human bone 
marrow stromal cells in an immature state during in vitro expansion (Martin et al., 
1997; Bianchi et al., 2003). Cell seeding density also plays a role in the expansion 
capacity of MSCs. Colter et al. demonstrated that higher expansion profiles of MSCs 
can be attained when plated at low density (1.5-3 cells/cm2) resulting in the 
remarkable increase in the fold expansion of total cells (Colter et al., 2000). Similar 
results were obtained by other researchers suggesting that MSC clones are highly 
heterogeneous with respect to their self-renewal capacity (Bianco et al., 2001; Basksh 
et al., 2004). In addition, coordinated activities of a number of signaling pathways, 
such as Wnt, Notch and BMP, have been reported to influence the process of 
self-renewal in a context dependent manner (Satija et al., 2007). In order to harness 
the clinical potential of MSCs, new protocols must be established which allows the 
generation of large numbers of MSCs without affecting their differentiation potential 
so as to meet the needs of tissue engineering. 
2.5.5 Differentiation potential of MSCs 
Considerable research has been done in assessing the ability of MSCs 
derived from a variety of different species to develop into terminally differentiated 
mesenchymal phenotypes both in vitro and in vivo. The commitment and 
differentiation of MSCs to specific matured cell types was influenced by the activities 
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of various transcription factors, cytokines, growth factors and extracellular matrix 
molecules. An optimal culturing strategy would involve mimicking the in vivo 
environment of MSCs. Under defined inductive conditions, MSCs are able to acquire 
characteristics of cells derived from embryonic mesoderm such as osteoblasts, 
chondrocytes, adipocytes, tendon cells, as well as cells possessing ectodermal and 
neuronal properties (Baksh et al., 2004) (Fig. 2.3). However, the molecular 
mechanisms that govern MSCs differentiation are incompletely understood. As lack 
of standard characterization method for other source of MSCs, bone marrow is still a 
traditional source of MSCs. Recently, MSCs from bone marrow have been shown to 
develop into various terminally differentiated cells and tissues including bone, 
cartilage, fat, muscle, tendon, pancreatic, neural tissue and liver (Johnstone et al., 
1998; Wakitani et al., 2002; Ryden et al., 2003; Woodbury et al., 2000; 
Sanchez-Ramos et al., 2000; Deng et al., 2001; Lee et al., 2004a; Shu et al., 2004). 
Since bone marrow derived MSCs hold promising for cell therapy, further research on 
characterizing their phenotype, understanding their mechanisms of action, optimizing 
their in vitro expansion, investigating their differentiation mechanism, and tracing 
their in vivo migration are necessary before clinical use. 
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 Figure 2.3 Mesenchymal stem cells multilineage differentiation potential. The 
stepwise cellular transitions from the putative mesenchymal stem cell to 
highly differentiated phenotypes are depicted schematically (Caplan and 
Bruder, 2001). 
 
2.4 Hepatogenic differentiation of mesenchymal stem cell 
2.4.1 Early liver development 
The process of liver development can be divided into several distinct stages 
based on molecular and functional properties (Fig. 2.4). Each stage of cell growth and 
differentiation is tightly regulated by extra- and intra-cellular communications, as well 
as cell autonomous mechanisms. The most essential extracellular signals include 
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fibroblast growth factors (FGFs), bone morphogenic proteins (BMP), Nodal (activin), 
hepatocyte growth factor (HGF), and oncostatin M (OSM) (Kinoshita and Miyajima, 
2002; Lemaigre and Zaret, 2004; Zhao and Duncan, 2005; Clotman and Lemaigre, 
2006; Shafritz et al., 2006). At the intracellular level, the liver-enriched transcription 
factors hepatocyte nuclear factor (HNF) 3α, β, HNF4α, HNF1α, β, HNF6, and 
CCAAT enhancer binding protein (C/EBP) α, β act consecutively, in essence, in a 
cross-regulatory manner, at specific developmental stages to regulate liver-specific 
gene expression (Duncan, 2000; Kinoshita and Miyajima, 2002; Lemaigre and Zaret, 
2004; Zhao and Duncan, 2005; Kyrmizi et al., 2006). 
 
Figure 2.4  Schematic presentation of fetal liver development. (Snykers et al., 2008). 
The initial event in the development is the commitment of the foregut 
endoderm stem cells to the hepatic epithelial lineages, which was regulated by FGFs 
(FGF1 and basic bFGF) from the cardiogenic mesoderm cells and BMPs (BMP2, 
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BMP4 and BMP5) from the septum transversum mesenchyme (Duncan, 2000; 
Kinoshita and Miyajima, 2002; Lemaigre and Zaret, 2004). At approximately rodent 
E9.0-9.5, cells start to massively proliferate and bud into the stromal environment of 
the septum transversum mesenchyme. The cells defined as bipotent hepatoblasts at 
this stage. Then (at rodent around E11-12), the liver primarily becomes a primarily 
hematopoietic organ. Hematopoitic stem cells (HSCs) which form the extrahepatic 
organ colonize the liver bud and secrete a growth signal for the liver, thereby, 
hepatoblasts continue to proliferate (Kinoshita and Miyajima, 2002; Lemaigre and 
Zaret, 2004). At commitment stage, three cells population which include bipotential 
hepatoblast, cholangiocyte-committed progenitor cells and hepatocyte-committed 
cells exist. Notch signaling pathways regulates the differentiation along the 
cholangiocytic lineage (Duncan, 2000; Lemaigre and Zaret, 2004; Shafritz et al., 
2006). Mesenchymal cells or nonparenchymal liver cells excrete HGF, which support 
the growth and differentiation of the fetal hepatocytes and hormone insulin, 
synergistically promotes this effect (Shafritz et al., 2006; Kinoshita and Miyajima, 
2002; Kamiya et al., 2001). Subsequently, cooperative action of OSM, mostly 
produced by HSCs, together with glucocorticoids induces partial hepatic maturation 
and suppression of embryonic hematopoiesis (Shafritz et al., 2006; Zhao and Duncan, 
2005; Kinoshita and Miyajima, 2002; Kamiya et al., 2001). Kinoshita and Miyajima 
demonstrated that OSM alone fails to induce differentiated liver phenotypes, implying 
the essence of glucocorticoids as triggers for hepatic maturation (Kinoshita and 
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Miyajima, 2002). Meanwhile, the number of bipotential hepatoblast is markedly 
reduced. Although cells continue to proliferate, most of them are unipotent and 
irreversibly committed to either the hepatocytic or cholangiocytic lineage (Shafritz et 
al., 2006; Zhao and Duncan, 2005; Lemaigre and Zaret, 2004). Complete functional 
hepatic maturation ultimately takes place after birth upon coassistance of HGF, 
produced by the surrounding nonparenchymal liver cells like sinusoidal, stellate, and 
endothelial cells (Kamiya et al., 2001).  
2.4.2 Hepatocyte differentiation of mesenchymal stem cells 
Mesenchymal stem cell differentiation to hepatocyte is driven by complex 
processes that are only beginning to be understood. The natural developmental 
process provides a great deal of information. Several growth factors and hormones are 
used to mimic these processes. Yet, the complexity of interactions between various 
cell types and their temporal changes make it difficult to replicate this process. On the 
other hand, non-natural or semi-toxic chemical drugs are often used to reset the cell’s 
preprogrammed status with some success. 
2.4.2.1 Growth factors/Cytokines/Corticosteroids/Hormones 
The pioneer study of hepatic differentiation of mesenchymal stem 
cells was discovered by Verfaillie and coworkers, who demonstrated that multipotent 
adult progenitor cells (MAPCs) found within adult bone marrow exposure to FGF + 
HGF + insulin-transferrin-sodium selenite (ITS) + dexamethasone gained the ability 
to undergo hepatic differentiation. MAPCs transformed into cells with morphological, 
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phenotypic, and functional characteristics of hepatocytes (Schwartz et al., 2002). 
However, the resultant population was far from homogeneous. Significantly 
optimized differentiation was obtained via exposure of bone marrow stem cells to the 
same hepatogenic factors, but in a time-specific sequential manner, reflecting their 
secretion pattern during the hepatogenesis in vivo. More than 85% of the thus 
sequentially cultured cells featured a highly differentiated hepatic phenotype and 
functionality, including inducible cytochrome P450 (CYP)-dependent activity 
(Snykers et al., 2006). The following studies showed that added either as a mixture 
(FGF + HGF; FGF + HGF + OSM) or separately (HGF; HGF/OSM; FGF/HGF/OSM) 
stimulation of MSCs which result in expression of distinct hepatocyte markers and 
functions, that is, albumin and urea secretion, glycogen storage, and low-density 
lipoprotein uptake (Kang et al., 2005; Shi et al., 2005; Li et al., 2006; Hong et al., 
2005; Lee et al., 2004a). The same result obtained by combinations thereof FGF + 
HGF followed by OSM (Ong et al., 2006; Talens-Visconti et al., 2006). In contrast, 
others emphasized the necessity of supplementary differentiation-inducing factors to 
enforce functional hepatic conversion of MSCs (Lange et al., 2005). Basically, soluble 
medium factors such as dexamethasone, ITS, and nicotinamide synergistically affect 
the hepatic driving pathways (Seo et al., 2005). In sharp contrast to the critical role of 
serum in MSC expansion, serum-free conditions have been successfully applied on a 
routine basis for hepatic differentiation of MSCs (Lee et al., 2004a; Talens-Visconti et 
al., 2006; Lange et al., 2005; Seo et al., 2005). 
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2.4.2.2 Reconstruction of in vivo cell-matrix and cell-cell interactions 
Cocultures of stromal bone marrow cells with primary hepatocytes 
were at first designated to develop long-term functional hepatic in vitro models 
(Mizuguchi et al., 2001). Jagged1 protein was considered responsible for the benign 
effects on hepatocyte differentiation by mediating differentiation events via the Notch 
signaling pathway (Mizuguchi et al., 2001; Okumoto et al., 2003). Later, Jagged1 and 
Notch were considered essential in drive bone marrow progenitors toward 
hepatocyte-lineage cells (Okumoto et al., 2003). In a recent study by Lange et al., 
coculture with liver cells was claimed to be the sole trigger able to shift MSC into 
cells with a hepatobiliary phenotype (Lange et al., 2005). The impaired differentiation 
capability of the chosen clonal MSCs or the high purity of high passaged MSCs (thus 
not contaminated with hematopoietic stem cells) was held responsible for failing 
growth factor-stimulated hepatic differentiation. Another critical factor affecting 
cellular differentiation status is the spatial distribution between cells (Aurich et al., 
2007; Luk et al., 2005). Differentiation is usually initiated upon 60%–100% 
confluence. Significantly promoted hepatic differentiation in areas of highest cellular 
density (maximal cell-cell contact) versus that in lower cellular density emphasized 
the relevance of intercellular communication during differentiation processes 
(Schwartz et al., 2002; Snykers et al., 2006; Hong et al., 2005; Ong et al., 2006; 
Aurich et al., 2007; Snykers et al., 2007). Minor roles are ascribed to the type of 
coatings used. The natural scaffold collagen turns out to be most effective (Snykers et 
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al., 2006; Snykers et al., 2007). 
2.4.2.3 Liver-enriched transcription factors (LETFS) overexpression 
By far, only one study has investigated the putative inductive effect 
of liver enriched transcription factors (LETFs) on hepatic differentiation of MSCs. 
More specifically, Talens-Visconti et al. confirmed the contribution of C/EBPβ in 
inducing adipose tissue-derived stem cells (ADSCs) and bone marrow-derived MSCs 
towards hepatocyte, however, C/EBPα failed to driving hepatic differentiation 
(Talens-Visconti et al., 2006). 
2.4.2.4 Epigenetic modification 
Epigenetic modification may contribute to overcome cell fate. 
Snykers et al. found previously that addition of 1 μM trichostatin A (TSA) to cultured 
human (h) MSCs, triggers their ‘‘transdifferentiation’’ into cells with phenotypic and 
functional characteristics similar to those of primary hepatocytes (Snykers et al., 
2007). In line with other reports that enhance hepatic differentiation upon addition of 
0.1% dimethylsulfoxide (DMSO) to hADSCs, prestimulated for 10 days with a 
mixture of hepatogenic cytokines (Seo et al., 2005). Recently, DNA methyl 
transferase inhibitors (DNMTis), either alone or combined with HDACis, also were 
introduced to alter cell fate (Milhem et al., 2004; Schmittwolf et al., 2005; Sgodda et 
al., 2007; Yoshida et al., 2007). Basically, DNMTis function as preconditioning agents 
before hepatic differentiation (Sgodda et al., 2007; Yoshida et al., 2007; Stock et al., 
2008), whereas HDACis act as stimulants during or after differentiation (Snykers et 
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al., 2006; Seo et al., 2005; Yamazaki et al., 2003; De Kock et al., 2008). In general, 
chromatin remodeling seems to be a potential innovative strategy to overcome cell 
fate determinism and favor lineage-specific differentiation. 
2.4.3 Characterization of hepatocyte-like cells 
Stem cell-derived hepatocyte-like cells may be characterized in vitro by 
their morphological, RNA expression, protein expression, and functional activity. 
Most studies that employed the use of endodermal markers include LETFs (HNF1α, β, 
HNF3β, HNF4α, and C/EBPα, β), plasma proteins (α-fetoprotein, albumin, 
transthyretin), and cytoskeletal proteins (CK18, CK8). A minority of studies have 
examined the expression of CYPs and other ‘‘late’’ enzymes such as tryptophan 2, 
3-dioxygenase (TO) and tyrosine amino transferase (TAT).  
The differentiation of stem cells toward the hepatocyte lineage often 
involves uncontrolled processes, resulting in a heterogeneous cell population. Some 
genes such as AFP and TTR are both expressed in liver tissue and in the extra 
embryonic yolk sac (Dziadek and Adamson, 1978; Gulbis et al., 1998). Hence, 
exclusive analysis of one of the latter markers cannot count as proof for a genuine 
hepatic phenotype. The need thus arises to identify genes that are predominantly 
expressed in the liver and not in other tissues, enabling an accurate follow-up of the 
differentiation process and precise characterization of the end populations. So the 
functional analyses need to be accounted. The ultimate proof of functional hepatic 
behavior is no doubt in vivo transplantation of ex vivo generated stem cells-based 
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hepatic cells in animal models with liver injury (Imamura et al., 2004; Tang et al., 
2006; Seo et al., 2005; Aurich et al., 2007; Luk et al., 2005; Sgodda et al., 2007; 
Brulport et al., 2007). Animal liver disease model like carbon tetrachloride-injured or 
dimethylnitrosamine-injured murine provides a suitable condition for transplant of ex 
vivo generated stem cells-based hepatic cells. Positive homing, engraftment, 
repopulation, and functional maturation are basically explored by means of molecular 
imaging techniques, immunohistochemistry, in situ hybridization, and serology, which 
give the evidence that stem/progenitor cells could contribute to liver reconstitution. 
Confirmation of the in vitro obtained results via rigorous in vivo tools might shed light 
on the therapeutic potential of stem/progenitor cells in various acute and chronic liver 
disorders. 
 
2.5 Fourier transforms infrared (FTIR) microspectroscopy  
FTIR microspectroscopy is a form of absorption spectroscopy that detects the 
vibrational characteristics of chemical functions within a sample by interrogating the 
absorption spectra of the sample using the mid-infrared region of light. Changes in the 
dipole moment of the sample molecule when infrared light is incident on it produces 
an absorption spectrum in a very specific wave number range characteristic for the 
chemical functional groups within that molecule. Both qualitative and quantitive 
information about chemical composition, functional group, and conformation may be 
determined. Thus, by analyzing the absorption spectrum, the biochemical nature of 
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the sample can be elucidated. FTIR microspectroscopy has been widely used in 
biophysical research, proven to provide sensitive and precise measurement of 
biochemical changes in biological cells and tissue (Lasch and Boese, 2002).  
This method has been recognized as an analytical tool in medical diagnostics. 
The differences in the absorbance spectra in the mid-IR region between normal and 
abnormal tissue have been shown to be a possible criterion for detection and 
characterization of various tissue sample, such as breast (Fabian et al., 1995), colon 
(Lasch et al., 1998), cervix (Chiriboga et al., 1998; skin (McIntosh et al., 1999), oral 
mucosa (Fukuyama et al., 1999), heart (Liu et al., 1999), liver (Chiriboga et al., 2000), 
lung (Yano et al., 2000) and brain (Kneipp et al., 2002). It also have been employed to 
study human (Bentley et al., 2007; Hoshino et al., 2007; Krafft et al., 2007; Heraud et 
al., 2010) and murine stem cells (Ami et al., 2008; Tanthanuch et al., 2010) 
characterization and differentiation by detecting and defining biochemical changes 
occurring during the differentiation process in the cells. These studies demonstrated 
that different cell types possessed distinct IR spectral phenotypes, which can be used 
to distinguish between stem cells and their derivatives. This approach has an ability to 
characterize different cell types by sensitive IR spectroscopic fingerprints and give the 
information changes in macromolecular cellular components such as lipids, proteins 
nucleic acids and carbohydrates (Miler et al., 2003) which seen as an easy, rapid, 
sensitive, nondestructive, noninvasive, label-free method which can be applied to 
monitoring or sorting large populations of cells (Downes et al., 2010). 
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Recently, synchroyton infrared microspectroscopy has been used for the 
early detection of live fibrosis (Liu et al., 2006). FTIR imaging analysis could become 
a valuable analytic method in brain tumor research and possibly in the diagnosis of 
human brain tumours (Bambery et al., 2006). Wang et al. used FTIR 
microspectroscopy to study the compositional changes in inflammatory 
cardiomyopathy and the results demonstrate chemical difference between the 
inflammatory responses in mouse model, providing insight into why the disease can 
be self-limiting in some cases while fatal in others (Wang et al., 2005). 
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CHAPTER III 
CHARACTERIZATION OF BONE MARROW DERIVED 
MESENCHYMAL STEM CELLS EXPANDED IN 
CULTURE 
 
3.1 Abstract 
Bone marrow mesenchymal stem cells (BM-MSCs) are multipotent adult 
stem cells that have emerged as promising candidates for cell therapy. The low 
frequency of this subpopulation of stem cells in bone marrow necessitates their in 
vitro expansion prior to clinical use. We evaluated the effect of initial seeding density 
and long term culture on cells’ proliferation, differentiation potential and phenotype. 
In this experiment, rat BM-MSCs (rBM-MSCs) could be isolated by using the 
selective plastic surface attached method. The growing fibroblastic cell population 
primarily consisted of spindle shaped and polygonal cells with significant renewal 
capacity as they were cultured at the density of 100 cells/cm2. The cell clones 
proliferated extensively with at least 33.4 population doublings with ten passages. 
Moreover, the cells expressed CD29, CD37 and CD105 but not CD34 and CD45 and 
they maintained mesenchymal (osteoblastic, chondrocytic, and adipocytic) 
differentiation potential in all passages analyzed. Our finding supports the concept 
that low initial seeding densities result in higher yields and faster expansion of 
rBM-MSCs, and this expansion culture fully retained the multipotent character 
of rBM-MSCs, which could maintain mesenchymal lineage differentiation 
potential and MSCs’ phenotype up to the 10th passage. This experiment provides the 
method which could be used to isolate, culture and expand relatively homogenous 
population of MSCs from adult rat bone marrow. 
 
3.2 Introduction 
Adult MSCs have generated immense research interest in cell base therapies 
owing to their mulipotentiality and capacity for self-renewal. Bone marrow stromal 
tissue has been regarded as the most likely source to obtain MSCs. Several preclinical 
and clinical studies have confirmed the great therapeutic potential of MSCs (Brooke 
et al., 2007; Caplan, 2007; Yu and Silva, 2008; Abdallah and Kassem, 2009). For 
MSCs’ preclinical applications, an adequate number of cells are necessary, and 
considering the low number of MSCs (Wexler et al., 2003; Caplan, 2007), an 
extensive ex vivo expansion is required. The MSCs culture conditions are crucial in 
order to maintain MSCs’ morphology and biological and functional properties intact 
for prolonged passages (Shahdadfar et al., 2005; Meuleman et al., 2006; Neuhuber et 
al., 2008; Pal et al., 2009).  
Isolation of MSCs relied on their ability to adhere to plastic surfaces and 
MSCs have been successfully isolated from human (Pittenger et al., 1999), feline 
(Martin et al., 2002), canine (Kadiyala et al., 1997), rabbit (Johnstone et al., 1998), rat 
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(Wakitani et al., 1995), baboon (Devine et al., 2001), goat (Mosca et al., 2000), sheep 
(Jessop et al., 1994), chicken (Berry et al., 1992), and pig (Ringe et al., 2002) bone 
marrow by selecting the clonally growing adherent cells plastic surface in cultures. 
The purity of MSCs in marrow adherent cells differs among species. Human and 
canine marrow adherent cells are relatively homogeneous and contain a high 
percentage of MSCs. In many respects, the rat is an ideal model to study the cell 
biology and biochemical characteristics of MSCs. However, there is no standardized 
method for culturing MSCs; specifically, there are no standards for seeding densities, 
levels of confluence, and duration of cell expansion. Some studies suggested that 
seeding MSCs at low density results in the most rapid proliferation as well as the 
highest percentage of multipotent cells (Colter et al., 2000; Javason et al., 2001; 
Sekiya et al., 2002; Neuhuber et al., 2008). Others have suggested that strict 
maintenance of very-low cell densities throughout expansion is necessary to select for 
homogeneous cultures of a subpopulation of cells with high proliferation and 
differentiation potential (Jiang et al., 2002; Reyes and Verfaillie, 2001). In fact, the 
heterogeneity cell populations exist in MSCs cultures among different species 
(Phinney et al., 1999a; Peister et al., 2004) even in MSCs donations obtained from the 
same human donor (Phinney et al., 1999b). What is well-recognized is the variability 
found in MSCs culture. It is obvious that these cultures are composed of different cell 
types with distinct morphologies. These cells type have been classified as 
spindle-shape type Ι and flattened type ІІ cells (Mets and Verdonk, 1981) or rapidly 
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self-renewing cells and mature MSC (Colter et al., 2000; Colter et al., 2001; Sekiya et 
al., 2002) by shape, marker expression and growth kinetics. How should these 
subpopulation be culture-expanded become the principal issue for preclinical study? It 
is necessary to use standardized culture protocols that preferentially expand undesired 
cells population. 
Long term expansion culture has proven that environmental conditions 
significantly increase and decrease the culture life span of MSCs. The telomere length 
of MSCs have been shown to shorten in culture expansion, leading to a gradual 
senescence, which is normally recorded in population doubling (PD) (Stenderup et al., 
2003; Baxter et al., 2004; Parach et al., 2004; ). In the high passages, MSCs showed a 
reduced sensitivity to undergo adipogenic differentiation (Muraglia et al., 2000; 
Goodwin et al., 2001; Campagnoli et al., 2001; Bieback et al., 2004; Bonab et al., 
2006). With this in mind, it is necessary to evaluate the effect of long term in vitro 
culture on the proliferation, differentiation and phenotype of MSCs. In the context, it 
is important to choose optimal culture condition to expansion of MSCs and maintain 
MSCs’ morphology and biological and functional property intact for prolong passages. 
We aimed to evaluate the effects of initial seeding density in culture on proliferation 
and cell morphology of rBM-MSC cultures and determine the phonotype and 
mesenchymal differentiation potential for long time culture. 
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3.3 Materials and Methods 
All chemicals used in this study were purchased from Sigma (Sigma 
Chemical Company, St. Louis, MO, USA). 
3.3.1 Isolation and culture of rBM-MSCs 
The rBM-MSCs were isolated from 8-week-old Wistar rats. The tibias and 
femurs were excised aseptically. The epiphyses were then removed, the marrow were 
flushed out with a stream of standard complete culture medium (CCM), which 
consisted of alpha-modified minimum essential medium (α-MEM) supplemented with 
10% fetal bovine serum (FBS; Gibco BRL, Grand Island, NY, USA) and antibiotics 
(streptomycin-penicillin) through a 20-gauge needle attached to a 5 ml syringe. The 
pooled cell suspension was centrifuged at 600 ×g for 5 minutes. The pellet was 
resuspended in CCM. The rBM-MSCs culture were performed by plating the cell 
suspension in a 75 cm2 tissue culture flask (Nunc, Roskilde, Denmark) containing 20 
ml of CCM at 37°C in a humidified atmosphere of 5% CO2. No culture medium 
changes were made in the initial two days; from the third day onwards, culture 
medium was changed every three days until the culture flask was confluent. Upon 
confluence the cells were detached with 0.25% trypsin and 1 mM ethylenediamine 
tetraacetic acid (EDTA) and the cells were seeding at 10, 100 or 1000 cells/cm2. The 
rBM-MSCs were passaged upon reaching 90% confluence. The rBM-MSCs were 
frozen and stored at each passage with culture medium supplement with 30% FBS 
and 7% dimethy solfexide (DMSO) in liquid nitrogen for future experiment. 
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3.3.2 Proliferation Kinetics   
The rBM-MSCs were passaged and counted once they reached a 
sub-confluence of 90%. The PD rate was determined using the following formula: 
X=log10 (NH) − log10 (N1)/log10 (2). NH is the harvested cell number and N1 is the 
seeded cell number. The PD for each passage was calculated and added to the PD of 
the previous passages to generate data for cumulative population doublings levels 
(PDL). 
3.3.3 Characterization of rBM-MSCs  
3.3.3.1 In vitro differentiation potential 
For osteogenic differentiation, rBM-MSCs were seeded in 6-well 
plates (Nunc) at a density of 5000 cells/cm2 and cultured in CCM for reaching 90% 
confluence. Thereafter, the CCM was removed and cells were incubated in osteogenic 
induction medium (OIM) for an additional 21days with media changes every other 
day. OIM consisted of CCM supplemented with 50 μM ascorbic acid, 100 nM 
dexamethasone and 5 mM KH2PO4. After 21 days, the cell monolayer was washed 
twice with PBS without calcium and magnesium [without calcium and magnesium 
[PBS (-)], fixed in 4% paraformaldehyde (PFA) for 10 minutes, and then stained with 
2% Alizarin Red solution (pH 4.1) for 15 minutes at room temperature. Following this 
the removal Alizarin Red solution was performed the cells were rinsed with PBS (-) 
1-2 times, recorded staining results with microphotography. Experiments were 
performed in triplicate. 
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To induce chondrogenic differentiation, rBM-MSC were plated in a 
6-well plate at 5000 cells/cm2 and cultured in CCM for reaching confluence. After 
confluence, cells were trypsinized and transferred to a 15 ml polypropylene conical 
tube (Nunc), centrifuged at 3000 rmp to create a pellet, and cultured 21 days in 
chondrogenic induction medium, including 15% FBS, 50 mg/ml ascorbate 
2-phosphate, 40 μg/ml proline, 1 mM pyruvate, 6.25 μg/ml ITS, 100 nM 
dexamethasone (Dex) and 10 ng/ml transforming growth factor-β (TGF-β) in α-MEM 
by feeding twice a week. Subsequently, the cell pellet was embedded in optimal 
temperature cutting (OCT; Richard-Allan Scientific, Kalamazoo, MI, USA) 
compound, sectioned at 5 μm in a cryostat at -18°C and mounted on slide. Then the 
cryosections were fixed with 4% PFA. Matrix deposition of glycosaminoglycan was 
detected by staining the cells with 1% Alcian blue in 3% acetic acid for 15 minutes 
and then the excess stain was rinsed with distilled water, air dried and observed under 
a light microscope and captured the image. 
The rBM-MSCs were plated in a 6-well plate at 5000 cells/cm2 and 
culture in CCM for reaching 90% confluence. To induce adipogenic differentiation, 
the cells were cultured in CCM supplement with 0.5 mM methylisobutylxanthine 
(IMBT), 1 μM Dex, 10 μg/ml insulin, 100 μM indomethacin and 4.5 g/ml glucose for 
up to 21 days. The medium was replaced twice weekly. Then the cells monolayer was 
washed with PBS (-), fixed with 4% PFA and stained with Oil red-O. The Oil red-O 
solution was prepared by vigorously mixing 3 parts solution (0.5% in isopropanol) 
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with 2 parts water for 5 minutes and filtered through a 0.4 μm filter. The cells were 
stained for 15 minutes to detect the lipid droplets within the differentiated cells. 
Excess stain was removed by rinsing with 60% isopropanol and water. Clusters of 
lipid droplets were detected by observing under a light microscope and captured the 
image. 
3.3.3.2 Phenotype determination by flow cytometry 
Clonal surface marker expression was characterized by flow 
cytometry. Confluent culture was harvested by treating with 0.25% trypsin/EDTA for 
3 minutes and pelleted at 600 ×g for 5 minutes. About 1x 106 cells were re-suspended 
in PBS (-), after being washed three times, followed by being incubated with primary 
unconjugated antibodies mouse anti-CD29 (1:150; BD Pharmingen, San Diego, CA, 
USA), mouse anti-CD34 (1:150; BD Pharmingen), rabbit anti-Endoglin (CD 105; 
1:100; Santa Cruz Biotechnology, CA, USA), rabbit anti-CD45 (1:100; Santa Cruz 
Biotechnology) and rabbit anti-CD73 (1:100; Santa Cruz Biotechnology) for 1 hour at 
room temperature. The cells were then washed and incubated with secondary antibody 
conjugated with either Alexa 488 donkey anti-mouse IgG (1:1000; Molecular probes, 
Eugene, OR, USA) or Rhodomine RedTM-goat anti-rabbit IgG (1:1000; Molecular 
probes) for 15 minutes. The cells stained with Alexa 488 donkey anti-mouse IgG or 
Rhodomine RedTM-goat anti-rabbit IgG were used as negative control. The cells were 
then washed and analysed by flow cytometry on a BD fluorescence activated cell 
sorter (FACSCaliburTM) flow cytometer using CellQuestTM software with 20,000 
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events recorded for each sample. For each marker, three independent samples were 
run. 
3.3.3.3 Immunocytochemistry 
The cells were fixed with 4% PFA solution for 30 minutes at room 
temperature, then washed three times with PBS (-), followed by incubation in 
blocking solution for 2 hours. The cells were subsequently incubated with the 
following primary antibody, mouse anti-CD29 (1:200, BD Pharmingen), mouse 
anti-CD34 (1:200, BD Pharmingen), rabbit anti-Endoglin (CD 105, 1:200, Santa Cruz 
Biotechnology), rabbit anti-CD45 (1:200, Santa Cruz Biotechnology) and rabbit 
anti-CD73 (1:200, Santa Cruz Biotechnology) at 4°C overnight. Afterword, the excess 
primary antibodies were washed out, the cells were treated with second antibody 
Alexa 488 donkey anti-mouse IgG (1:1000, Molecular probes) or Rhodomine 
RedTM-goat anti-rabbit IgG (1:1000, Molecular probes) for 1 hour. The cells were 
co-stained with 4’6’-diamidino-2-phenylindole (DAPI) for 5 minutes and then 
examined under florescence microscopy. For negative controls, replacing the primary 
antibodies with normal rabbit serum or staining without secondary antibody was 
investigated in each experiment, and in either case, no specific positive staining was 
detected. 
3.3.4 Statistical analysis 
All data are represented as arithmetic mean ± SD. The data collected in ten 
passages was compared by Repeated Measurement analysis of variance test. P. values 
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only less than 0.05 (P< 0.05) were considered significant. 
 
3.4 Results 
3.4.1 Generation of primary cultures from adherent bone marrow cells 
After plating the bone marrow cells, only a few cells attached to the surface 
of plastic culture flasks and formed adherent cells within one week. The onset of 
colony formation could be observed at first after 4 to 7 days. Cells confluence was 
reached after approximately 12 days of culture. These rBM-MSCs grown from the 
bone marrow suspension by selective attached to plastic tissue culture flask exhibit 
two major subpopulations: 1) cells with an elongated, spindly shape with two 
processes that extend in opposite directions from the cell body (Figurer 3.1 a-c); and 2) 
polygonal cells with or without short processes or large flattened cells (Figurer 3.1 
d-e). During initial growth, they formed colonies, that is, the colony-forming-unit 
fibroblasts (CFU-F) (Figurer 3.1 f and g) and dislodged readily on tripsinization in 3 
minutes. 
3.4.2 Effect of seeding density on expansion of rBM-MSCs 
The rBM-MSCs were plated at densities of 10, 100, 1000 cells/cm2, and 
expanded from passage 1 to passage 5 (10 cells/cm2) or passage 10 (100 and 1000 
cells/cm2) up to 61 days, with replicate cultures counted each day (Fig 3.2). When 
rBM-MSCs plated at low density of 10 cells/cm2, the cells expanded up to 33.4 
population doublings over about 61 days in culture (passage 5) with a the population 
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doubling time of 87.6 hours. When the rBM-MSCs plated at 100 cells/cm2, the cells 
had completed 54.1 populations doubling in 64 days culture (passage 10) and with a 
population doubling time of 28.3 hours. When the rBM-MSC plated at high density of 
1000 cells/cm2, displayed a population doubling time of 36.2 hours over 21.2 
population doublings (10 passage; 32 days in culture). When the rBM-MSC plated at 
density of 100 cells/cm2, the cells exhibited three phases of growth kinetics: lay phase, 
a log phase of rapid growth and a stationary phase. 
The rBM-MSC growth patterns were found to have a difference in initial 
plating density. MSCs plated at 10 cells/cm2 grew into few large, very dense colonies. 
The more numerous colonies formed by cell plated at cells/cm2 were smaller and less 
dense. MSCs plated at 1000 cells/cm2 grew evenly on the plastic (Fig 3.3). 
3.4.3 Charaterization of rBM-MSCs from efficiency expansion culture 
3.4.3.1 Expression of mesenchymal markers in rBM-MSCs 
The mean percent of CD expression of the five antigens was 
compared using Repeated Measurement Analysis of Variance at passage 1, 5 and 10 
(Figure 3.4). Results demonstrated that the number of positive of CD29 (73±2.3, 
80±0.5, 89.4±1.2, respectively), CD73 (69.5±1.8, 72.8±0.4, 76.3±0.8, respectively) 
and CD105 (72.5±1.2, 79.4±0.2, 82.1±0.9, respectively) increased, meanwhile CD34 
(22.5±2.6, 12.8±0.9, 8.1±2.1, respectively) and CD45 (24.5±0.5, 17.6±0.7, 9.2±0.3, 
respectively) decreased for extent expansion, indicating that the changes in 
marker-positive population associated with reduction in marker-negative population. 
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The expression of CD29, CD105, CD34 and CD45 were significantly different 
between passage 1 and passage 10, and no different in the CD73 expression. The 
results showed that rBM-MSCs at higher passages displayed elevated expression of 
mesenchymal markers with more uniform distributions.  
3.4.3.2 Immunophenotype 
Typical CD29, CD34, CD45, CD73, CD90 and CD105 surface 
marker expressions were detected in rBM-MSCs culture at passage 5 (Figuer 3.3). 
The results demonstrated that the cells were negative for CD34 and CD45, cell 
surface markers associated with lymphohematopoietic cells. Therefore, there was no 
evidence of hematopiotic precursors in the cultures. In contrast, the rBM-MSCs 
expressed CD29, CD73 and CD105, consistent with their undifferentiated state. 
Basically, identical results were obtained by FACS examination. 
3.4.3.3 Differentiation potential 
The differentiation capacity was quantitatively assessed at passage 1, 
5 and 10.  Adipogenic differentiation was apparent after 1 week of incubation with 
adipogenic supplementation. By the end of the third week, all passages examined 
contained numerous oil Red-O positive lipid droplets (Fig 3.6 a, d and g). As showed 
in Fig 3.6 b, e and h, there were osteoblasts like morphological changed in the 
rBM-MSCs, and many mineral depositions were observed on the surface in all 
passage analyzed. In chondrogenic differentiation assay, rBM-MSCs of all passages 
analyzed consolidated within 1 day, forming aggregates that dislodged to float freely 
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in the suspension culture. After 21 days differentiation, cryosections of the aggregates 
stained with Alcian blue showed a condensed structure with chrondrocyte like lacunae 
(Fig 3.6 e, f and i). These suggested that rBM-MSCs maintain mesenchymal 
differentiation potential for extended expansion.  
 
3.5 Discussion 
In our experiment, we found that two major subpopulations of rBM-MSCs 
existed in the culture, one is a spindle shape and the other is a polygonal shape cell 
and these cells maintained these phenotypes in every passage. The rBM-MSCs 
attained in our laboratory were similar to previous reports in morphological 
characteristics and the trait of growth (Aizi et al., 1998; Colter et al., 2000; Colter et 
al., 2001; Javazon et al., 2001; Sekiya et al., 2002). Colter et al. (2000) used FACS for 
analysis and demonstrated that stationary cultures contained a major population of 
large and moderately granular cells and a minor population of small and a granular 
cell which is referred to as recycling stem cells or RS-1 cells. During the lag phase, 
the RS-1 cells gave rise to a new population of small and densely granular cells (RS-2 
cells). During the late log phase, the RS-2 cells decreased in number and regenerated 
the pool of RS-1 cells found in stationary cultures. In other previous studies (Sekiya et 
al., 2002; Colter et al., 2001), spindle-shaped cells have been classified as 
‘‘immature,’’ while polygonal cells have been characterized as ‘‘mature’. Because the 
correlation between cell shape and stem-cell characteristics has yet to be definitively 
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determined, Neuhuber et al. (2008) described the two subpopulations simply as 
“spindle-shaped” and “flat”. They found that time is a critical factor for increased 
proportions of flat cells and they cultured spindle-shaped and flat cells superlatively, 
and found that the cells maintained these phenotypes even in between subsequent 
passages. Most clones could be cultured with at least ten passages and approximately 
20 population doublings, showing neither changed morphology nor reduced 
proliferation. Some protocols strived to select for these cells in culture (Smith et al., 
2004; Neuhuber et al., 2008), however, there is no clear evidence that this specific 
population is more efficacious in animal models of diseases and injury. This relatively 
subpopulation may not be the determining factor as the beneficial effect of MSCs, but 
may rely on secretion of therapeutic factors and regulation of extracellular matrix 
molecules, in addition, the identity of the desirable subpopulation may depend on 
specifics of the disease and therapy. 
Previous studies have suggested that low initial seeding densities resulted in 
higher yields and faster expansion of MSCs (Colter et al., 2000; Sekiya et al., 2002). 
Cells seeded at low densities yielded more doublings per passage, as growth at higher 
densities becomes constrained by density-dependent growth inhibition. In our hands, 
rBM-MSCs seeded at 100 cells/cm2 had the fastest doubling times. A possible reason 
may be that cell-to-cell contact or factors that the cells secrete into the medium will 
affect the growth rate (Colter et al., 2000; Javazon et al., 2001; Neuhuber et al., 2008). 
Our results showed that the growth patterns of rBM-MSCs cultures also depended on 
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the initial seeding densities. At low seeding density, rBM-MSCs grew as very dense 
colonies (Fig 3.3 a-c), whereas at high seeding density, rBM-MSCs spread evenly 
across the plate (Fig 3.3 d-f). In addition, at intermediate density, the growth pattern 
was a mix of colonies, neither as densely clustered as the ones observed at low plating 
density, nor as single cells dispersed across the plate observed at high seeding density 
(Fig 3.3 g-f). This indicated that the difference in growth patterns can certainly affect 
growth kinetics. In the dense colonies observed at low seeding density, cell growth is 
likely to be inhibited at the colony center because of contact inhibition. Conversely, 
the sparse single cell distribution observed at high seeding density may not have 
provided sufficient stimulus for growth and loss of cell-cell contact. Gregory et al. 
(2005) suggested that MSCs differentiation is affected by the microenvironment 
presented both at the center of dense colonies and in the sparse colony periphery, so 
the similar mechanisms may also regulate cell proliferation. Seeding cells sparsely 
without a program of early re-seeding to avoid overcrowding at the colony center may 
affect proliferation directly or indirectly through the induction of early differentiation 
of rBM-MSCs. In order to avoid this problem, seeding cells at intermediate densities 
is necessary. 
We found optimal rBM-MSCs growth at a seeding density of 100 cells/cm2, 
and further characterization of rBM-MSCs yielded at this seeding density. MSCs 
expression of cell surface antigens and differentiation into other lineages has been 
used as markers for the multipotent nature of these cells (Pittenger et al., 1999). The 
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results showed that the rBM-MSC maintained the phenotype and mesenchymal 
differentiation potential even at high passages (Passage 10). The rBM-MSCs at higher 
passages displayed elevated expression of mesenchymal markers with more uniform 
distributions indicated the homologous populations were yielded. The previous 
reports showed that MSCs lost adipogenic potential and osteogenic potential drop at 
high passages (Digirolamo et al., 1999; Conget and Minguell, 1999; Sekiya et al., 
2002), in our hands, we found that rBM-MSCs maintenance high differentiation 
potential up to the passage that we analyzed (passage 10). The possible reason maybe 
attributed to the initial density of the rBM-MSCs, which have been shown to still have 
a high proliferation potential at high passages, as seen in the population doubling 
levels (Fig 3.2). The rBM-MSCs at this suitable seeding density seem possible that 
paracrine or autocrine factors secreted into the medium are responsible for the 
transition. 
 
3.6 Conclusion 
MSCs from adult rat bone marrow were successfully isolated, cultured and 
expanded by using the selective plastic surface attached method. A relatively 
homogenous population was attained. The results confirmed that low initial seeding 
density affects the growth of kinetics and morphology of rBM-MSCs and the initial 
seeding density is critical for the long-term culture of rBM-MSCs. The homologous 
population of rBM-MSC yield at less passage 10. This study provides an optimal 
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culture condition for later experiment. 
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 Figure 3.1  Morphology of primary cultures of rBM-MSCs. A subpopulation of 
rBM-MSCs exhibit elongated, spindle shaped cells (a-c). A second 
subpopulation of rBM-MSCs exhibit flattened polygonal morphology 
with short or no processes (d-f). Colony-forming-unit fibroblasts (CFU-F) 
of rBM-MSCs after 7 days (g) and 12 days (h) cultivated. Original 
magnification, (a-f) 200×; (g, h) 40×. 
66 
 Figure 3.2  The growth kinetics of rBM-MSCs plated at different densities across 
multiple passages. rBM-MSCs were plated at 10 cells/cm2, 100 cells/cm2 
and 1000 cells/cm2 and cumulative population doubling level (PDL) and 
doubling times were calculated. 
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 Figure 3.3  The growth patterns of rBM-MSCs plated at different initial plating 
densities. Micrographs depict growth patterns of rBM-MSC plated at 10 
cells/cm2 (a-c), 100 cells/cm2 (d-f) and 1000 cells/cm2 (g-i). Pictures are 
representative of cultures one day after seeding (a, d and g), mid-way 
through the culture (b, e and h) and on the day of passaging (c, f and i). 
Original magnification, 40×. 
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Figure 3.4  FACS analyses of the selected surface antigens expression by the 
rBM-MSCs during expansion in culture. rBM-MSCs at passage 1 (a, d, g, 
j and m), passage 5 (b, e, h, k and n) and passage 10 (c, f, i, l and o) were 
incubated with CD29 (a-c), CD73 (d-f), CD105 (g-i), CD34 (j-l) and 
CD45 (m-o) and analyzed by FACS Callibur cytometer and cell Quest. 
Black lines represent control patterns obtained without primary antibody, 
whereas black areas represent antibody against the indicated 
mesenchymal markers. Numbers in panels represent mean fluorescent 
intensity of the cells expressing each marker. 
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 Figure 3.5  Immunocytochemistry analyses of rBM-MSCs at passage 5. rBM-MSCs 
at passage 5 was stained with CD29 (Green), CD73 (Red), CD105 (Red), 
CD34 (Green), CD45 (Red) and DAPI (Blue). Original magnification, 
200×. 
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 Figuer 3.6  Differentiation potential of rBM-MSCs. The rBM-MSCs at passage 1 (a, 
b and c), passage 5 (d, e and f) and passage 10 (g, h and i) were 
subjected to adipogenesis, osteogenesis, chondrogenesis and assays by 
Oil Red-O staining (a, d and g), Alizarin Red staining (b, e and h) and 
Alcian blue staining (c, f and i), respectively. Original magnification, (b, 
e and h) 40×; (c, e and i) 100×; (a, d and g) 200×. 
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CHAPTER IV 
DISCRIMINATION OF FUNCTIONAL MESENCHYMAL 
STEM CELLS DERIVED HEPATOCYTE USING FTIR 
MICROSPECTROSCOPY 
 
4.1 Abstract 
Applying mesenchymal stem cells (MSCs) to therapy liver disease, carefully 
monitor and fully characterizes of functional hepatocyte differentiated in vitro are 
needed. This study employed Fourier transform infrared (FTIR) microspectroscopy to 
investigate the characteristics of rat bone marrow mesenchymal stem cells 
(rBM-MSCs) derived hepatocytes by detecting biochemical and molecular 
composition changes during hepatogenesis process. Principal Component Analysis 
(PCA) enables us to discrimination the maturation stage of rBM-MSCs derived 
hepatocytes from undifferentiation rBM-MSCs, the induction and the differentiation 
stage of rBM-MSCs derived hepatocytes by their FTIR “marker bands”. The 
predominant discriminating factors responsible for this separation were identified at 
the following vibrational frequencies: 3012 cm-1 (cis C=C stretch), 2952 cm-1 (νas 
CH3), 2854 cm-1 (νs CH2) and 1722 cm-1 (C=O stretching of unsaturated acid), which 
possible associated with triglyceride and unsaturated fatty acid accumulation in 
hepatocytes for attaining their function. Base on these finding, we suggested that the 
rBM-MSCs derived hepatocytes are characterized by high lipid content which 
facilitates a means of identifying hepatocytes from their derived stem cells by 
using FTIR microspectroscopy. These results supported that FTIR microspectroscopy 
is sensitive for monitoring the differentiation state of stem cells under hepatogenic 
induction particularly at late stage. It provides biochemical information that is 
complimentary to that obtained from conventional techniques, and may give 
unambiguous results. In addition, this approach is more straightforward, 
non-destruction and requires less sample preparation compared with the conventional 
methodologies. 
 
4.2 Introduction 
Practical application of stem cells for regenerative medicine, a number of 
normal cells differentiated from stem cells are needed to carefully characterize prior 
to their use for clinical transplantation by rapid low-cost assays. However, in 
existence methods assay, such as immunocytochemistry, flow cytometry, gene 
expression studies for functional end cells have been showed to have their restrictions 
use in practical since time consuming as well as requiring biomarker or label. In 
addition, these established methods could not monitor various cell types originating 
from stem cells at the same time. New methods which can be applied both on the 
single cell level and large populations of cells would be established by monitoring 
stem cells differentiation in vitro.  
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The emergence of biospectroscopy in cell biology gives a promising tool for 
stem cell research (Heraud and Tobin, 2009). This biospectroscopy analyses stem cells 
by using Fourier transform infrared (FTIR) microspectroscopy which have been 
employed to study human (Krafft et al., 2005; Bentley et al., 2007; Hoshino et al., 
2007; Heraud et al., 2010) and murine stem cells (Ami et al., 2008; Tanthanuch et al., 
2010) characterization and differentiation by detecting and defining biochemical 
changes occurring during the differentiation process in the cells. These studies 
demonstrated that different cell types possessed distinct IR spectral phenotypes, which 
can be used to distinguish between stem cells and their derivatives. This approach has 
an ability to characterize difference cell type by sensitive IR spectroscopic fingerprints 
and give the information changes in macromolecular cellular components such as 
lipids, proteins nucleic acids and carbohydrates which seen as an easy, rapid, sensitive, 
nondestructive, noninvasive, label-free method which can be applied to monitoring or 
sorting large populations of cells (Miler et al., 2003; Downes et al., 2010). 
Due to the ethic controversy of embryonic stem cells research and the 
problem of sources shortages in other adult stem cells, mesenchymal stem cells 
(MSCs) have been regarded as one of the most promising cell therapeutics for liver 
disease (Xu et al., 2008).  More recently, an in vitro direct differentiation model 
employing growth factors and cytokines know to induce hepatic from MSCs has been 
developed (Schwartz et al., 2002; Lee et al., 2004). As the liver plays a central role in 
metabolism, the stem cells derived hepatocytes are needed to be carefully 
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characterized including the function assay in vitro.  
The process of embryonic liver development includes the early stage, mid 
stage and late stage in vivo. In this study we have used the hepatic differentiation 
protocol which mimics the embryonic liver development in vivo to induce rBM-MSCs 
differentiation to hepatocyte and distinguish each differentiation stage by using FTIR 
microspectroscopy. Aim to determine FTIR markers to characterization of each stage 
with an easy way.  
 
4.3 Materials and Methods 
4.3.1 Isolation, culture and characterization of rBM-MSCs 
rBM-MSCs isolation, culture and characterization implemented employing 
the same protocol as in chapter 3. 
4.3.2 Hepatic differentiation 
Passage 4 rBM-MSCs culturing at 100% confluence were used for 
hepatocyte differentiation assays. Hepatic differentiation from rBM-MSCs was 
performed as described with some modifications (Talens-Visconti et al., 2006). 
rBM-MSCs were serum deprived for 2 days (conditioning step) in Iscove's Modified 
Dulbecco's Medium (IMDM) supplemented with 10 ng/ml basic fibroblast growth 
factor (bFGF) and 20 ng/ml epidermal growth factor (EGF). Then a 2 step protocol 
was performed. Step 1 medium consisting of IMDM supplemented with 20 ng/ml 
hepatocyte growth factor (HGF), 10 ng/ml bFGF and 4.9 mmol/L nicotinamide for 7 
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days. Step 2 medium consisting of IMDM supplemented with 10 μmol/ml ITS (insulin, 
transferring and selenous acid, BD), 1μmol/ml dexamethasone (Dex) and 20 ng/ml 
oncostatin M (OSM) for 14 days. Medium were changed twice weekly. The different 
differentiation stages were defined as follow: step 1 (induction stage); step 2 for 7 
days (differentiation stage) and 14 days (maturation stage). 
4.3.3 Immunocytochemistry for hepatocyte specific marker.  
At the last day of differentiation, the cells were fixed with 4% 
paraformaldehyde solution for 30 minutes at room temperature, and then washed three 
times with PBS (-), followed by incubation in blocking solution for 2 hours. The cells 
were subsequently incubated with the following primary antibody mouse 
anti-α-Fetoprotein (AFP; 1:200), rabbit anti-mouse albumin (ALB; 1:100, Abcan, 
Cambridge, UK), rabbit anti-hapatocyte nuclear factor 3β (HNF3β; 1:200, Santa), goat 
anti-hapatocyte nuclear factor 1α (HNF1α; 1:200, Santa), mouse anti-cytokeratin 18 
(CK18, 1:200, Santa), goat anti-CCAAT/enhancer-binding proteins α (C/EBPα; 1:200, 
Santa) at 4°C overnight. Afterword, the excess primary antibodies were washed out, 
the cells were treated with second antibody Alexa 488 donkey anti-mouse IgG (1:1000, 
Molecular probes) or Rhodomine RedTM-goat anti-rabbit IgG (1:1000, Molecular 
probes) or Alexa 594 donkey anti-goat IgG (1:1000, Molecular probes) respectively 
for 1 hour. The cells were co-stained with DAPI for 5 minutes and then examined 
under florescence stereomicroscopy. 
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4.3.4 Indocyanine green (ICG) uptake study.  
ICG (25 mg) was dissolved in 5 ml of solvent in a sterile vial and then 
added to 20 ml of DMEM containing 10% FBS. The final concentration of the 
resulting ICG solution was 1 mg/ml. The ICG solution was added to the cell culture 
dish and incubated at 37°C for 15 minutes. The dishes were rinsed three times with 
PBS (-), the cellular uptake of ICG was examined with a stereomicroscope.  
4.3.5 Periodic Acid-Shiff (PAS) histochemical staining.  
Differentiated hepatocytes were immersed in periodic acid solution for 5 
minutes at room temperature and rinsed three times with distilled water. Cells were 
treated with Schiff’s reagent for 15 minutes at room temperature, washed in running 
tap water for 5 minutes, and examined with light microscope. 
4.3.6  Albumin ELISA.  
Cell culture medium at the induction stage, the differentiation stage and 
the maturation stage was collected as samples for albumin ELISA following 
manufacture’s instructions. Sample from 5 separate cultures were analyzed in 
triplicate for each group.  
    4.3.7  Urea production 
The cells of each stage that is the induction stage, the differentiation stage 
and the maturation stage were incubated with medium containing 5 mM NH4Cl for 24 
hours and the supernatant were measured colometrically in the culture media 
according to the manufacture’s instructions (Quantichrom Urea assay kit, Bioassay 
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Systems). Fresh culture media supplemented with 5 mM NH4Cl was used as negative 
controls. Sample from 5 separate cultures were analyzed in triplicate for each group. 
4.3.8   Reverse transcription-polymerase chain reaction (RT-PCR) analysis 
The total cellular RNA was extracted from cells using the Trizol reagent 
according to standard protocols and its purity was assessed by the absorbance ratio 
260/280 nm. RNA integrity was examined by agarose gel electrophoresis. cDNA 
samples were synthesized from 1 µg of total RNA by using a Super Script II 
first-strand synthesis system (Invitrogen, Carlsbad, CA) with a-oligo(dT)-adaptor 
primer according to the manufacturer's instructions. The cDNA preparation template 
was used for subsequent PCR amplification by using Taq DNA polymerase. PCR 
amplifications were performed using specific primers (Table 4.1) in a final volume of 
25 ml. The PCR conditions were: 1) 95°C for 3 minutes; 2) 30 cycles of 30 seconds at 
95°C, 30 seconds at 54°C for and 30 seconds at 72°C. Samples were electrophoresed 
on a 1.5% agarose gel and nucleic acids were visualized by ethidium bromide 
staining. 
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Table 4.1 Primers used for RT-PCR characterization 
Primer Sequence Size 
(bp) 
References 
AFP S: 5’-GAGAGTTGCCCAGCATACGAA-3’ 
A: 5’-CCTTGTCATACTGAGCGGCTA-3’ 
198 Hasuike et 
al., 2005 
ALB S: 5’-GAGACTGCCCTGTGTGGAAGA-3’ 
A: 5’-CTTTCCACCAAGGACCCACTA-3’ 
186 Hasuike et 
al., 2005 
HNF-3β S:5’-CCTACTCGTACATCTCGCTCATCA-3’ 
A: 5’-CGCTCAGCGTCAGCATCTT-3’ 
178 Li et al., 2008
CYP2B1 S: 5’-GAGTTCTTCTCTGGGTTCCTG-3’ 
A: 5’-ACTGTGGGTCATGGAGAGCTG-3’ 
196 Li et al., 2008
GAPDH S: 5’- TGCCCCCGACCGTCTAC-3’ 
A: 5’- ATGCGGTTCCAGCCTATCTG-3’ 
180 Hasuike et 
al., 2005 
 
4.3.9  Sample preparation for FTIR microspectroscopy 
Samples were collected at different culturing point as follows: the 
undifferentiated rBM-MSCs, the induction stage, the differentiation stage and the 
maturation stage. The sample were washed with PBS (-) for three times and removed 
from the culture dishes after treatment with 0.05% trypsin/0.5 mM EDTA for 3 
minutes. The suspension were centrifuged at 600 ×g for 5 minutes and washed three 
times in a physiological solution (0.9% NaCl in distilled water). The number of cells 
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was counted with a hematocytometer and adjusted the concentration of 1 x 106/ml, 
then deposited onto indium tin oxide-coated, silver-doped glass slide (MirriIR, Yienta 
Sciences, OH, USA) air-dried, and stored in the desiccators until spectra were 
acquired. 
4.3.10 FTIR microspectroscopy and data analysis 
FTIR measurement was carried out on the IR end station at Synchrotron 
Light Research Institute (Public Organization), Thailand. The IR data acquisition was 
performed by the Bruker Hyperion 2000 microscope (Bruker Optics Inc., Ettlingen, 
Germany) equipped with a nitrogen cooled MCT (HgCdTe) detector with a 36×IR 
objective, coupled to the Bruker Vertex 70 spectrometer. IR spectra were obtained 
from a reflection mode by collecting 64 scans, 68×68 µm aperture size at a resolution 
of 4 cm-1 over a measurement range of 4000-600 cm-1. Spectral acquisition and 
instrument control was performed using OPUS 6.5 (Bruker) software. 
The Principal Component Analysis (PCA) was conducted on spectra in the 
range of 3050-2800 cm-1 and 1750-750 cm-1 by using Unscrambler 9.7 software 
(CAMO, Oslo, Norway). All the original IR spectra were processed by taking the 
second derivative using the Savitzky–Golay algorithm with nine points of smoothing 
which allow to minimizing the effects of variable baselines and normalized with 
multiplicative signal correction (EMSC) which normalizes spectra, accounting for 
differences in sample thickness. Six PCs were chosen for analysis, and loading for 
each PC were plotted for each sample. Scores plots were used to visualize any 
87 
clustering of spectra, and loading plots were used to explain which spectral region 
most account to the variance in the dataset.  
Unsupervised hierarchical cluster analysis (UHCA) was performed in the 
spectral range of 3050-2800 cm-1 and 1750-750 cm-1 by using Ward’s algorithm, 
which express a matrix defining inter-spectral distances and merge the similar IR 
spectra into groupings.  
4.3.11 Statistical analysis 
Data are presented as mean ± SEM. The results were analyzed by 
Student’s t-test. P< 0.05 was considered statistically significant. 
 
4.4 Results  
4.4.1  Characterization of rBM-MSC derived hepatocyte 
Upon hepatic differentiation medium, rBM-MSCs underwent a drastic 
morphological change, which developed a hepatocyte-like morphology, defined as a 
round or polygonal shape, cytopasmic granulation and a central nucleus with 
prominent nucleolus, fibroblastic cells, however, persisted through the differentiation 
process (Fig.4.1). To determine whether differentiated cells showed the characteristic 
expression of hepatic phenotype markers, total RNA from cells was isolated at the 
induction step, the differentiation stage and the maturation stage. RNA transcripts of a 
number of hepatocyte-specific genes such as HNF3β, AFP (early hepatic markers), 
ALB (mid-late hepatic marker) and CYP2B1 (late hepatic marker) were examined by 
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RT-PCR (Fig. 4.2). Undifferentiated rBM-MSCs were used as negative controls and 
the rat adult liver cells were used as positive control. Evident AFP and HNF3β 
expression appeared at the induction stage and continued to expression through out 
the whole differentiation stages. Albumin expression appeared at the differentiation 
stage and continued to expression until the maturation stage. CYP2B1 only expressed 
at the maturation stage. The change in key liver-enriched factors indicated that the 
differentiation protocol was effective in driving rBM-MSCs toward a hepatic 
phenotype. To confirm the homogeneous expression of HNF3β, AFP (early hepatic 
markers), ALB (mid-late hepatic marker) and HNF1α (late hepatic marker) in 
differentiated cell populations, immunocytochemistry was used to examine the 
expression of these markers in the differentiated cells. The results showed that the 
cells expression of these liver specific marker at the maturation stage (Fig. 4.3). The 
results demonstrate that the levels of hepatic protein markers increased in rBM-MSCs 
in response to the differentiation protocol, which consistent with mRNA expression 
analysis. 
In order to test whether the differentiated cells possessed liver cell 
function, we measured liver function of the differentiated cells. Albumin and urea 
synthesis, as well as glycogen production and ICG uptake, are unique characteristics 
of hepatocyte. We assayed glycogen storage of the differentiated cells using PAS 
staining. Glycogen staining was present in the cell at the maturation stage (Fig. 4.4 a). 
ICG uptake showed that the differentiated cells could uptake ICG at the maturation 
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stage (Fig. 4.4 b). rBM-MSCs showed no activity of albumin and urea synthesis, 
glycogen production or ICG uptake in their undifferentiated stage. At the 
differentiation stage, rBM-MSCs cultured in hepatic differentiation media gained urea 
synthesizing capabilities. At the induction stage, the induced cells began to secrete 
albumin at a level of 0.32.± 0.87 μl/ml. At the maturation stage, the albumin 
concentration of the medium significantly increased up to 3.12.± 0.25 μl/ml, 
significant higher than that at the differentiation stage (P<0.05, Fig. 4.4 c). The urea 
concentration of the media was 0.56 ± 0.17 ng/cell/hour at the induction stage (P< 
0.05), and increased up to 1.98 ± 0.51 ng/cell/hour at the differentiation stage (P< 0.05, 
Fig. 4.4 d). The results suggested that rBM-MSCs derived hepatocyte produce 
liver-specific protein and are functional in vitro. 
4.4.2  FTIR microspectroscopy  
The hepatic differentiation processes of rBM-MSCs were followed by 
spectral changes using FTIR microspectroscopy. In order to eliminate individual 
bands that may overlap in the unprocessed spectra to be visualized, the spectra were 
converted to the second derivatives and following normalization to correct for 
differences in sample thickness (Schmid et al., 1997). The average second derivative 
FTIR spectra presented significant spectral changes in bands associated with lipid 
region (3050-2800 cm-1), protein region (1760-1350 cm-1) and nucleic acid region 
(1350-900 cm-1) (Fig. 4.5). Existing literature was used to tentatively assign some of 
the main peaks contributing to the variance (Table 4.2).  
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The spectral differences between culturing stages were observed in 
3050-2800 cm-1 region, which is dominated by acyl chain stretching vibrations with 
fatty acids of lipids as showed in Fig. 4.5 a. This region are assigned to C-H stretching 
modes, the symmetric and asymmetric C-H stretching vibrations of CH2 occur at 2852 
cm-1 and 2923 cm-1, while the symmetric and asymmetric mode of CH3 fall at 2873 
cm-1 and 2958 cm-1, respectively. The spectral profile of this region is similar 
excepting the bands intensity, thus reflects the degree of lipid content in cells. From 
the undifferentiated rBM-MSCs to the induction stage, the lipid content remained 
approximately constant. However, the lipid bands were observed to increase 
dramatically along differentiation, which reached the highest intensity at the 
maturation stage of differentiation. It is interesting to note that the main lipid head 
group (νsC=O stretching at 1740 cm-1) of all differentiation stages showed close 
spectral position and intensity. Beside, the extra peak at 1712-1722 cm-1 
corresponding to the C=O stretching of ester group of α and β unsaturated acids was 
observed to increase along differentiation stages, whereas the strong band shift from 
1712 to 1722 cm-1 was observed upon the maturation stage. Noteworthy, the cis 
double bond C=C at 3010 cm-1 associated with unsaturated fatty acids was observed 
to dramatically increase throughout the hepatic differentiation process. The band at 
1170 cm-1 (C-O stretch of esters) was observed to increase during differentiation. The 
results demonstrated that the maturation stage cells showed highest lipid concentration 
compare with the undifferenatiation rBM-MSCs, the induction stage and the 
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differentiation stage cells, which might be reflected to the producing of the new lipid 
species. 
The region from 1760 to 1350 cm-1 (Fig.4.5 b) gives information to the 
total cell protein content in each differentiation stage. The amide I region (1700-1600 
cm-1) provides information of protein secondary structure, containing four 
predominate components: intermolecular β-sheet (1639 cm-1), α-helix (1652 cm-1), 
β-turn (1681 cm-1) and β-sheet (1695 cm-1). The relative intensity of these components 
was observed to change when hepatic differentiation took place, indicating that 
different proteins were expressed during differentiation process. Undifferentiated 
rBM-MSCs presented highest intensity of α-helix structure (1652 cm-1), β-turn (1681 
cm-1) and β-sheet (1695 cm-1). These bands intensity showed sequentially decrease 
through differentiation stage, suggesting that protein content was likely to be reduced 
along differentiation process. In addition, the spectral profile of amide II region (1511 
cm-1 to 1580 cm-1) presented significant changed at the maturation stage. It was found 
the random coil position of amide II showed duplex peak at 1546 cm-1 and 1552 cm-1 
in all differentiation stage, except the maturation stage cells found absent of 1552 cm-1 
band. Moreover, undifferentiated rBM-MSCs presented strongly band at 1511 cm-1 
which give highest intensity over all differentiation stage. This band represents 
aromatic C=C stretching that might be reflected to protein containing high aromatic 
amino group. Therefore, the observation of different amide II structure might be 
connected to the transition of protein species to served hepatic function.  
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In the nucleic acid region from 1350-900 cm-1, three principal bands were 
identified and assigned. As can be seen in Fig. 4.5 c, these bands respectively occurred 
at 1240 cm-1 (νasPO2-), 1085 cm-1 (νsPO2-) and 970 cm-1 (RNA ribose phosphate main 
chain), which were found to changes in intensity during hepatic differentiation. The 
band at 1240 cm-1 were observed to change in peak position and intensity during 
differentiation, which was the peak position shift to 1232 cm-1at the induction stage 
and backed to 1240 cm-1 at the differentiation stage and the maturation stage. The 
band intensity at 1240 cm-1 and 1085 cm-1 decreased at the maturation stage of 
differentiation indicating that the differentiation finish and the band intensity at 970 
cm-1 which assigned to RNA, seen to increases in the induction stage and the 
differentiation stage of differentiation, indicating that mRNA translation take place 
and active to produce the proteins that the new phenotype are expressed, which in line 
with the protein secondary structure change. 
4.4.3  Multivariate analysis 
To identify the significant spectral variation upon differentiation process, 
principal component analysis (PCA) was applied to identify potential rBM-MSCs 
derived hepatocyte markers. PCA is a widely accepted method that enables the 
similarities and differences of spectral to be more readily identified. The scores 
indicate which objects are responsible variety spaces, while loading plot is used to 
highlight the contribution of each spectral frequency to each PC. PCA decomposition 
performed on the second derivative spectra from each differentiation stage. The results 
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showed that the first two PCs explained the best variance in experimental datasets in 
PCA models. These PCs accounting for 86% total variance (Fig. 4.6 a). PCA analysis 
provides the potential FTIR marker for discriminate cell stage of differentiation. The 
distinct separation between the differentiation stage cells and the undifferentiated 
rBM-MSCs, the induction stage cells is observed in the PCA scores plot along PC1, 
which explained 51% total variance (Fig 4.6 b), except the maturation stage cells, 
which was separated along PC2 from other stages (explaining 35% total variances). 
The PC1 loading plot shows the differences in α-helix protein secondary structure 
(positive loading at 1648 cm-1) and aromatic C=C stretching (at 1511 cm-1), employed 
to differentiate the undifferentiated rBM-MSCs, the induction stage cells from the 
differentiation stage cells, is important discriminator. Meanwhile, the major 
contributing peak for the differentiation stage cells separated from others stages cells 
was 1658 cm-1 (α-helix), with further peaks of 2915 cm-1 (νasCH2), 2850 cm-1 (νsCH2), 
1618 cm-1 (amide I), 970 cm-1 (RNA ribose phosphate main chain), which revealed in 
the PC1 negative loading.  
The difference between the maturation stage cells and the undifferentiated 
rBM-MSCs, the induction stage cells in term of lipid, protein secondary structure and 
nucleic acid were revealed in the PC2 loading plot, which explained 35% total 
variance (Fig. 4.6 b). The absorption band at 2925 cm-1 (-CH3, -CH asymmetrical 
stretch), 2854 cm-1 (-CH2, -CH symmetrical stretch) and 1722 cm-1 (C=O stretch) are 
highly positively correlated with PC2, indicating high lipid content in this stage of cell, 
94 
which could be used as marker bands to separate the undifferentiated rBM-MSCs 
from other stage. Importantly, the band at 1722 cm-1 associated to C=O stretch only 
appeared in maturation stage cells and was hence highly correlated to this stage. The 
negative loading at lipid bands (2946 cm-1, 2912 cm-1 and 2842 cm-1), protein bands 
(1658 cm-1, 1552 cm-1, 1469 cm-1) and nucleic acid band (1087 cm-1) was employed to 
discriminate undifferentiated rBM-MSCs and the induction stage cells from other 
stages, indicating different lipid content, protein secondary structure and DNA/RNA 
content in these stage. 
UHCA was used to study the similarity of spectra between rBM-MSCs 
and rBM-MSCs derived hepatocytes in the regions of 3050-2800 cm-1 and 
1750-800cm-1.  Second derivative FTIR spectra were vector normalized and UHCA 
applied using Ward’s algorithm. The dendrogram represented in the Fig 4.7 permits to 
identify three major clusters of spectra. There was no misclassification among each 
group. The spectra of the maturation stage cells were clearly separated from other 
stages. The induction stage cells and the differentiation stage cells have the similar 
spectra. This is further evidence for the distinct FTIR spectral profiles corresponding 
to the three cell types as revealed by PCA, and described above. 
 
4.5 Discussions 
The induce hepatocyte protocol used in this study have been demonstrated to 
efficient and convenient way to induce rBM-MSCs to hepatic lineage, the results 
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showed that the differentiated cells displayed the hepatocyte like morphology, 
expressed of hepatic specific gene and protein, functioned as adult liver cells, in 
accordance with previous studies (Wang et al., 2004; Seo et al., 2005; Chien et al., 
2006; Sgodda et al., 2007). 
Conventional method to characterization of stem cell derived hepatocyte has 
been demonstrated that the cells we attained were genuine hepatocyte. We wanted to 
found the easy way to characterization of stem cell derived hepatocyte, in this aim, we 
employed FTIR microspectroscopy to detect the process of differentiation and identify 
FTIR “marker bands” related to biochemical changes that occurred during the 
differentiation of rBM-MSCs to hepatocytes. The spectral feature we attained from the 
maturation stage of rBM-MSCs derived hepatocytes were showed to similar to that 
from human HepG2 cells (Najbjerg et al., 2011). Our results showed that lipid content 
increase dramatically along differentiation, which reached the highest intensity at the 
maturation stage of rBM-MSCs derived hepatocyte during differentiation. This 
increasing in lipid content was consistent with the hepatocyte function: synthesis of 
lipoproteins, storage of triglycerides by carbohydrates metabolism (Dentin et al., 
2006). Moreover, insulin and glucose were added as basic components in hepatogenic 
differentiation medium might play a key role on induction of gene involving hepatic 
lipogenesis and lipogenic enzyme activity (Guillen and Cabo, 1997; Han et al., 2009). 
In addition, the cis double bond C=C at 3010 cm-1 associated with unsaturated fatty 
acids was also observed to dramatically increase through hepatic differentiation 
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process. Observation of both C=O and C=C stretching confirm the accumulation of 
unsaturated fatty acid by hepatocytes. Previous research has shown that the 
unsaturated fatty acids protect normal cells against the damage induced by saturated 
fatty acids, since the excess fatty acids are toxic to cells (Listenberger et al., 2003). 
Therefore, the unsaturated fatty acid in hepatocyte might play a key role on 
lipotoxicity prevention (Walker, 2004). In addition, an increase in unsaturated fatty 
acids band might be attribute to remodeling of phosphatidylcholine (PC) which need 
to acquire their appropriate fatty acid composition (Zhao et al., 2008).   
Important insights to the protein region showed that undifferentiated 
rBM-MSCs presented highest intensity of α-helix structure (1652 cm-1), β-turn (1681 
cm-1) and β-sheet (1695 cm-1). These bands intensity showed to sequentially decrease 
through differentiation stage, suggesting protein content was likely to reduce along 
differentiation process. As we know, during the process of hepatic differentiation in 
vitro, AFP begin to expression at the early-stage and through at mid-stage, while ALB 
expression begin at mid and late stage (Aurich et al., 2007). These two proteins have 
been showed to contain high α-helix secondary structure (Laskowski et al., 1997). The 
α-helix band intensity at the maturation stage were observed to decrease compared 
with the differentiation stage, indicating that the number of AFP positive cells 
decreased, which consist with previous study (Lee et al., 2004, Sato et al., 2005). 
Moreover, we found that undifferentiated rBM-MSCs presented strongly band at 1511 
cm-1 which give highest intensity over all differentiation stage. This band represents 
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aromatic C=C stretching that might be reflected to protein containing high aromatic 
amino group (Barth, 2000). Blondheim and his group reported the expression of 8 
genes in adult human MSCs relating to the dopamine synthesis which up rise to the 
tyrosine level in cells as dopamine precursor (Blondheim et al, 2006). Thus, 
rBM-MSCs might probably have similar pathway that reflect the accumulation of 
aromatic tyrosine in cells. Therefore, the observation of different amide II structure 
might be connected to the transition of protein species to served hepatic function. 
Furthermore, the intensity of bands in the nucleic acid region, at 1240 cm-1 
(νasPO2-), 1085 cm-1 (νsPO2-) and at 970 cm-1 (RNA ribose phosphate main chain) 
was observed to decrease. Symmetric and asymmetric modes of PO2- have been 
attributed to DNA backbone structure (Chiriboga et al., 2000), were decreased at the 
maturation stage of differentiation indicating that the differentiation finish and the 
hepatocytes possessed low proliferation rate (LeCluysse et al., 1995; Rogiers and 
Vercruysse, 1998). The band at 970 cm-1 assigned to RNA, increased from 
undifferentiated rBM-MSCs to the induction stage and the differentiation stage, 
finally decreased at the maturation stage, indicating that mRNA translation take place 
and active to produce the proteins that the new phenotype are expressed, which in line 
with the protein secondary structure changes. 
 
4.6 Conclusions 
The results show that the FTIR microspectroscopy is a powerful approach to 
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directly probe the biochemical changes observed in the process of rBM-MSCs 
differentiation into hepatocyte. Combining FTIR spectra with PCA and UHCA, 
provide an efficiency method to discrimination of hepatocyte from their origins. PCA 
analysis provided information of possible biochemical changes occurring during the 
differentiation processes, whereas, UHCA methods could used to discriminate and 
classify the different differentiation stages. The most promising marker located at lipid 
region, which appears important for segregation IR spectral of rBM-MSCs derived 
hepatocyte. FTIR microspectroscopy has been showed to be a sensitive method to 
discriminate differentiated cell from their stem cells origins, which represent a simple, 
reagent-free, for monitoring and characterization of the process of stem cell 
differentiation and would potential be an alternative technique which complementary 
to other immunocytochemistry methods. 
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 Figure 4.1  Changes in cell morphology during hepatic differentiation of rBM-MSCs. 
Cells exhibited fibroblast like morphology at conditioning stage (a), 
small round, oval islands morphology at the induction stage (b), and 
hepatocyte like morphology at the maturation stage (c), respectively. 
Original magnification, 40 ×. 
 
 
Figure 4.2  RT-PCR analyses of the temporal expression pattern of selected 
hepatocyte specific gene during hepatic differentiation of rBM-MSCs. 
AFP, HNF 3β, ALB and CYP2B1 expression were analyzed at the 
induction stage, differentiation stage and maturation stage. 
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 Figure 4.3  The expression of AFP, HNF 3β, CK18, HNF 1α, ALB and C/EBPα at 
the maturation stage of differentiation by immunocytochemistry. 
Original magnification, 100 ×. 
 
Figure 4.4  The induced rBM-MSCs showed liver function. Glycogen staining (a), 
ICG uptake (b), albumin secretion (c) and urea concentration (d) at the 
maturation stage of differentiation. Values represent means ± SD. 
Significance was set at P< 0.05.Original magnification, 40 ×. 
d
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a b
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Table 4.2 FTIR frequencies and tentative band assignments 
Wavenumber 
(cm-1) 
Assignment Reference 
~3010 cis =CH stretch Guillen and Cabo, 1997 
~2958 CH asym. stretch of –CH3 Socrates, 2001 
~2923 CH asym. stretch of –CH2 Socrates, 2001 
~2873 CH sym. stretch of –CH3 Socrates, 2001 
~2852 CH sym. stretch of –CH2 Socrates, 2001 
~1743 C=O stretch (ester) Guillen and Cabo, 1997 
~1722 C=O stretch (ester) Nara et al., 2002 
~1695 aggregated β-sheet structures Bocker et al., 2007 
~1681 antiparallel β-sheet structures Bocker et al., 2007 
~1639 antiparallel β-sheet structures Bocker et al., 2007 
~1627 antiparallel β-sheet structures Bocker et al., 2007 
~1580~1511 Amide II Socrates, 2001 
~1240 PO2- asym. stretch  Diem et al., 2008 
~1085 PO2- sym. stretch  Bocker et al., 2007 
~970 RNA ribose phosphate main 
chain 
Wood et al., 2000 
asym: asymmetric; sym: symmetric. 
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Figure 4.5  Average second derivative FTIR spectra of rBM-MSCs differentiation 
into hepatocyte-like cell. (a) Shows an enlargement of lipid region 
(3000-2800cm-1); (b) shows an enlargement of the protein region 
(1760-1350 cm-1); (c) shows an enlargement of nucleic acid region (1350 
-900 cm-1). 
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Figure 4.6  PCA scores plots (a) and loding plot (b) of rBM-MSCs differentiation 
into hepatocytes. Spectra were process to the 2nd derivative over the 
spectral rang between 3000-2800 cm-1 and 1800-800 cm-1. 
104 
 Figure 4.7 Cluster analysis of different stage of rBM-MSCs differentiation to 
hepatocytes. 
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CHAPTER V 
CHROMATIN REMODELING AGENTS IN HEPATIC 
DIFFERENTIATION OF BONE MARROW 
MESENCHYMAL STEM CELLS AND ANALYSIS BY 
FTIR MICROSPECTROSCOPY 
 
5.1 Abstract 
Epigenetic events, including covalent histone modifications and DNA 
methylation, are acknowledged to play fundamental roles in the determination of 
lineage-specific gene expression and cell fate decisions. This study was aimed to 
investigate whether the DNA methyl transferases inhibitors (DNMTi) 
5-Aza-2’-deoxycytidine (5-Aza-dC) and histone deacetylases inhibitors (HDACi) 
Trichostatin A (TSA) could promote the hepatic differentiation potential of rat bone 
marrow mesenchymal stem cells (rBM-MSCs). This study also employed the Fourier 
Transform Infrared (FTIR) microspectroscopy to monitor the biochemical and 
molecular composition changes upon 5-Aza-dC and/or TSA exposure during hepatic 
differentiation. Results demonstrated that exposure of rBM-MSCs to 1 μM TSA in 
both the differentiation and the maturation stage considerably improved hepatic 
differentiation. More specifically, TSA enhanced the hepatocyte-shape development, 
and promoted chronological expression of hepatic proteins, such as α-Fetoprotein 
(AFP), albumin (ALB), hapatocyte nuclear factor 3β (HNF3β), hepatocyte nuclear 
factor 1α (HNF1α), cytokeratin 18 (CK18) and CCAAT/enhancer-binding proteins α 
(C/EBPα). In addition, TSA improved the hepatic function, including glycogen 
storage, Indocyanine green (ICG) uptake, albumin and urea secretion. Meanwhile, the 
treatment of rBM-MSCs with 20 μM 5-Aza-dC only or in combination with TSA 
ineffectively improved hepatic differentiation. The major spectral differences between 
5-Aza-dC and/or TSA treated cells and untreated cells were identified at the following 
vibrational frequencies: 3012 cm-1 (cisC=C stretch), 2958 cm-1 (νasCH3), 2923 cm-1 
(νasCH2), 2852 cm-1 (νsCH2), 1743 cm-1(νsC=O stretch), 1722 cm-1 (C=O stretching 
of unsaturated acid), 1652 cm-1 (α-helix), 1627 cm-1 (intramolccular β-sheet), 1085 
cm-1 (DNA/RNA) and 970 cm-1 (DNA/RNA). These differences suggested that 
5-Aza-dC and/or TSA affect the biochemical composition of the cells, which 
indicated that FTIR microspectroscopy provides an explorative method in monitoring 
how the chromatin remodeling agent functions on the cells. 
 
5.2 Introduction 
Liver development from the endodermal layer is known to proceed via 
several distinct steps that involve extracellular signals induced by growth factors and 
cytokines. Numerous cytokines and growth factors have been shown to have potent 
effects on hepatic growth and differentiation in vitro (Lee et al., 2004; Snykers et al., 
2006; Talens-Visconti et al., 2007). The importance of the sequential addition of 
liver-specific factors in a time-dependent manner that resembles the secretion pattern 
during liver embryogenesis was demonstrated (Snykers et al., 2006). A variety of 
biochemical cocktails have been developed for promoting the differentiation of adult 
stem cells into hepatocytes (Snykers et al., 2006; Talens-Visconti et al., 2007; 
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Kinoshita and Miyajima, 2002; Lee et al., 2004). However, the potential of 
differentiation attained in existing methods is still low. Mechanisms underlying MSCs 
overcoming lineage borders and trans-differentiation to hepatocyte is unclear. Initial 
attempts for improvement were mainly focused on mimicking the in vivo situation and 
addition of soluble medium components. Recently, epigenetic modifications on the 
procedures of differentiation have received much more attention. This is due to their 
fundamental role on the controlling of differentiation (Snykers et al. 2009). Epigenetic 
modifier including DNA methyltransferases inhibitors (DNMTi), such as 
5-Aza-2’-deoxycytidine (5-Aza-dC), 5-azacytidine (5-Azac) and histone deacetylases 
inhibitors (HDACi), such as trichostatin A (TSA) and dimethtlsulfoxide (DMSO) 
were commonly used.  
Trichostatin A (TSA) is an organic compound that specifically inhibits 
classes I and II mammalian histone deacetylase (HDAC) by binding directly to the 
catalytic site of HDAC (Finnin et al. 1999). The TSA function has interfered with the 
removal of acetyl groups from histones (histone deacetylases, HDAC) and therefore 
altered the ability of DNA transcription factors to access the DNA molecules inside 
chromatin (Medina et al. 1997). Histone acetylating is generally associated with gene 
activation. The previous studies showed that exposure to TSA, the phenotype of 
normal primary rat hepatocytes were maintained in vitro culture, implying that 
epigenetic alterations could represent a method to develop phonotypical stable 
primary hepatocyte cultures (Papeleu et al. 2003; Henkens et al. 2007). Consequently, 
the hypothesis was made that epigenetic alterations could represent a novel approach 
to develop phenotypically stable primary hepatocyte cultures. Since chromatin 
remodeling also plays a central role during organogenesis in regulating differentiation 
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and stem cell functions. The further reports demonstrated that, exposure of 1 μM TSA 
to culture human BM-MSC and rat mesechymal progenitor cells (rMPC) pre-treated 
for 6 days with hepatogenic stimulating agents, the functional hepatocytes were 
achieved, indicating that TSA could function as a stimulant during or 
post-differentiation of hepatic differentiation (Snykers et al. 2007b; De Kock et al. 
2008). 
5-Aza-2'-deoxycytidine (5-Aza-dC) is a strong inducer of DNA 
de-methylation. It is an analogue of cytosine, that when incorporated into DNA, 
irreversibly binds the methyltransferase enzymes as they attempt to methylate the 
cytosine analogue. This depletion of methyltransferase in the cell results in passive 
de-methylation, which is known to reactivate epigenetically silenced genes (Mossman 
et al. 2010). 5-Aza-dC was applied to maintain differentiation in normal mouse 
primary hepatocyte (Rogiers et al. 2008). Exposure 5-Aza-dC for 24 hours prior to 
hepatic stimulation which is needed to be successful to induce hepatic differentiation 
of murine BM-MCS (Yamazaki et al. 2003), rat ADSC (Sgodda et al. 2007), human 
BM-MSC (Aurich et al. 2007), human umbilical cord blood MSC (Yoshida et al. 
2007). In the context, the results showed that 5-Aza-dC could be function as 
precondition agent prior to hepatic differentiation (Snykers et al., 2009). 
FTIR microspectroscopy has been extensively used for the study of 
conformational changes of molecules and molecular interactions. This method 
provides specific information regarding the biochemical composition of the sample. 
The unique characteristics of IR absorption bands of cellular components such as 
proteins (amide I band at 1650 cm-1, amide II at 1545 cm-1 and amide III at 1300 cm-1), 
lipids (CH stretching bands at 3000-2800 cm-1, CO stretching from ester groups at 
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1730 cm-1) and nucleic acids (asymmetric PO2 stretching from nucleic acids at 1240 
cm-1, symmetric PO2 stretching from nucleic acids at 1080 cm-1) can be used for the 
identification or characterization of biomolecular samples. Moreover, changes in these 
absorbance bands (e.g. changes in shape, intensity or shifts in peak position) are 
useful to pinpoint the differences or changes in samples, structures and states of 
biological specimens.  
Up to now, such HDMTi and DNMTi are mostly applied separately, and 
there is no report comparing the effect of both combined and single exposure to 
5-Aza-dC and TSA on the process of hepatogenisis. We were interested to evaluate 
and compare the effect of such chromatin remodeling agent on the rBM-MSCs 
differentiation to hepatocyte and employed FTIR microspectroscopy to monitor 
biochemical and molecular composition changes of the cell upon such chromatin 
remodeling agent treatment during hepatogenesis. 
 
5.3 Materials and Methods 
5.3.1 Isolation and culture of rBM-MSCs 
rBM-MSCs isolation and culture was implemented employing the same 
protocol as in chapter 3. 
5.3.2 Hepatic differentiation 
The standard hepatogenic protocol was done using the same protocol as in 
chapter 4. The different chromatin remodeling agents were added to the standard 
hepatogenic medium at different points of time. These culture conditions included 
(Table 5.1): (1) group 1: rBM-MSCs were pretreated 20 μM 5-Aza-dC for 24 hours 
and 1 μM TSA was added to both of the differentiation and maturation steps. (2) 
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Group 2: rBM-MSCs were pretreated 20 μM 5-Aza-dC for 24 hours and 1 μM TSA 
was added to the maturation step. (3) Group 3: rBM-MSCs were pretreated 20 μM 
5-Aza-dC for 24 hours. (4) Group 4: 1 μM TSA was added to both of the 
differentiation and maturation steps. (5) Group 5: 1 μM TSA was added to the 
maturation step. (6) Group 6: the standard hepatogenic medium as the control group.  
 
Table 5.1 Chromatin remodeling agent inducing hepatic differentiation protocols  
Condition Step Time 
G1 G2 G3 G4 G5 G6 
Pre-treatment 24 hours 
5-Aza- 
dC 
5-Aza- 
dC 
5-Aza- 
dC 
   
Conditioning 48 hours       
Induction 7 days       
Differentiation 7days TSA   TSA   
Maturation 7days TSA TSA  TSA TSA  
 
5.3.3 Characterization of hepatocyte-like cells  
The liver specific proteins and genes expression, as well as the liver 
functional assays were implemented using the same protocol and methodology of 
chapter 4. Positive cell numbers were obtained by counting the number of positive 
cells out of 1000 culture cells. The data is presented as mean ± SEM. The results were 
analyzed by Student’s t-test. P< 0.05 was considered statistically significant. 
5.3.4 FTIR microspectroscopy and data acquisition 
Cell samples were collected from different groups at different cultural 
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points as follows: the induction step, the differentiation step and the maturation step. 
The sample preparations were using the same methods as in chapter 4.  
Spectra were collected by the Bruker Hyperion 2000 microscope equipped 
with a nitrogen cooled MCT detector with a 36×IR objective, coupled to the Bruker 
Vertex 70 spectrometer. IR spectra were obtained from a reflection mode by collecting 
64 scans, 68×68 µm aperture size at a resolution of 4 cm-1 over a measurement range 
of 4000-600 cm-1. Spectral acquisition and instrument control was performed using 
OPUS 6.5 software. 
5.3.5 Statistical analysis 
The PCA was performed with The Unscrambler 9.7 using the spectra in the 
range of 3050-2800 cm-1 and 1750-750 cm-1. All the original IR spectra were 
processed by taking the second derivative using the Savitzky–Golay algorithm with 
nine points of smoothing which allow for minimizing the effects of variable baselines 
and normalized with multiplicative signal correction (EMSC) which normalizes 
spectra, accounting for differences in sample thickness. Six PCs were chosen for 
analysis, and loading for each PC were plotted for each sample. Scores plots were 
used to visualize any clustering of spectra, and loading plots were used to explain 
which spectral regions most accounted for the variances in the dataset.  
The relative areas (in percent) were calculated by the integral area of the 
curve for lipid (cis double bond C=C from 3020-3000 cm-1, C-H stretching vibration 
from 3000-2800 cm-1 and C=O stretching vibration from 1750-1720 cm-1), for amide I 
protein (1700-1600 cm-1), for DNA/RNA (1336-944 cm-1). The relative integrated 
area (in percent) of the macromolecular component was calculated in normalized 
second-derivative infrared spectra by using OPUS 6.5 software. Data was given as 
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means ± SD; P<0.05 and was considered significantly different. Error bars indicate 
standard errors of the means. 
 
5.4 Results  
5.4.1 The effect of 5-Aza-dC and TSA on the hepatogenic process 
5.4.1.1 Morphological features 
To determine the differentiation efficacy of the chromatin 
remodeling agent, rBM-MSCs culture were exposed to 5-Aza-dC and TSA separately 
or in combination at different inducing time points (Table 5.1). Results reveal that 
5-Aza-dC did not effect the changes of cell morphology in the treatment groups (G 1, 
2 and 3) during the pretreatment and the conditioning step, which presented 
fibroblastic shape (Fig 5.1). At the induction step, cell morphology of all experimental 
groups has developed to be epithelioid shape. The cells in 5-Aza-dC treated groups (G 
1, 2 and 3) were found to have three days delay in morphological changes, compared 
to those in control group 6. As the differentiation progressed, the change in cellular 
morphology was gradual in all experimental groups. At the differentiation step, 
islands of adherence round or polygonal-shaped cells surrounded by spindle-shape 
cells were observed in all experimental groups. Remarkable changes in cell 
morphology were observed in group 4 at this step, which displayed hepatocyte-like 
morphology, defined as cytoplasmic granulation and a central nucleus with prominent 
nucleolus, but was not observed in control group 6, indicating TSA promoted the 
hepatic differentiation. At the maturation step, cells underwent a drastic 
morphological change in all experimental groups compared with those at the 
beginning of differentiation. However, the sizes of such islands were observed to be 
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different in each group. Group 4, with exposure of TSA at both the differentiation and 
the maturation steps, showed the largest size of such islands. The smallest sizes were 
observed in group 3 which were exposed to 5-Aza-dC only. In addition, the same 
sizes were observed in group 1, 2, 5 and 6.  
5.4.1.2 Liver-specific protein expression 
To evaluate whether the morphological changes in 5-Aza-dC and/or 
TSA treated cells were associated with the changes in expression patterns at the 
protein level, the expressions of early (HNF3β, AFP), mid-late (ALB, CK18) and late 
(HNF1α, C/EBPα) hepatic markers were performed by immunocytochemistry. The 
cells from all experimental groups chronologically expressed HNF3β, AFP, ALB, 
CK18, HNF1α and C/EBPα (Fig 5.2), but the patterns and the levels of expression 
were different in each group (Fig 5.3). The positive rate was calculated by counting 
the positive cells out of 1000 total cells for each experimental group. At the induction 
step, the number of HNF3β positive cells in 5-Aza-dC treated groups (G1, 2 and 3) 
were significantly lower than that in control group 6 (10±12%, 6±11% and 8±21% vs. 
13±12%, respectively), while, the number of AFP positive cells were not significantly 
different, which consisted with the result of morphology change, indicating 5-Aza-dC 
delay the hepatic differentiation. By comparison, the cells in all experimental groups 
did not express or low express of ALB, CK18, HNF1α and C/EBPα. At the 
differentiation step, the positive cell numbers of all analyzed markers were observed 
to increase except AFP. In TSA only treated Group 4, the number of HNF3β, ALB, 
CK18, HNF1α and C/EBPα positive cells were significantly higher comparing with 
control group 6 (45±6% vs. 33±7%; 35±6% vs. 18±12%; 32±5% vs. 14±1%; 25±19% 
vs. 18±20%; 24±3% vs.18±5%, respectively). The numbers of positive cells of all 
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analyzed markers were significantly lower in 5-Aza-dC only treated group 2 and 3 
compared with control group 6. There was no significant difference of ALB (17±16% 
vs.18±21%), CK18 (15±2% vs.14±1%), HNF1α (18±13% vs.18±1%) and C/EBPα 
(12±1% vs.18±5%) positive cells between combination of TSA and 5-Aza-dC group 
(G1) and control group 6. At the maturation step, the cells in control group 6 
expressed AFP, ALB, CK18, HNF1α, C/EBPα and low levels of HNF3β, indicating a 
complete hepatocyte differentiation. The number of positive cells express HNF3β, 
AFP, ALB, CK18, HNF1α, C/EBPα were significantly higher in group 4 comparing 
with that in control group 6 (10±2% vs. 4±1%; 49±1% vs. 32±4%; 41±1% vs. 30±4%; 
45±9% vs. 27±3%; 34±5% vs. 25±14%; 33±3% vs. 28±1%, respectively). There was 
no significant difference of the positive cell number expression of all analyzed 
markers between group 1, 2, 5 and control group 6. 5-Aza-dC treated only group 3, 
however, was found to have a lower expression of all analyzed markers compared 
with control group 6.  
5.4.1.3 Liver-specific gene expression 
To determine whether morphologic changes were sustained and 
associated with the induction of hepatocyte-specific genes, the total RNA was isolated 
at the induction step, the differentiation step and the maturation step. RT-PCR was 
used to analyze the expression of early (HNF 3β and AFP) and mid-late (ALB and 
CYP2B1) genes (Fig 5.4). Undifferentiated rBM-MSCs and rat adult liver cells were 
used as negative and positive controls, respectively. At the induction step, the cells 
expression of HNF 3β and AFP, but not expression of ALB and CYP2B1 were 
detected in all experimental groups. At the differentiation step, the ALB expression 
was detected in control 6, as well as group 1, 4 and 5, but not in group 2 and 3. In 
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addition, the CYP2B1 expression was only found in group 4. Moreover, HNF 3β and 
AFP continued to be expressed in all experimental groups. At the maturation step, the 
cell in control group 6 lost to expression of HNF 3β and began to express CYP2B1. 
Meanwhile, the expression patterns of all genes in group 1, 4 and 5 cells were 
observed as the same as adult liver cells. Moreover, the cells continued to the 
expression of AFP in all experimental groups and ALB expression was detected in all 
experimental groups. 
5.4.1.4 Hepatic functionality 
To evaluate whether these rBM-MSC-derived hepatocyte-like cells 
also acquired typical functional hepatic features, ALB and urea secretion, glycogen 
production and storage and ICG uptake were analyzed at the last day of hepatic 
differentiation (Fig 5.5). TSA, added to both of the differentiation and maturation step 
(G4) significantly increased glycogen production, ICG uptake, ALB and urea 
secretion when compared with control group 6, while, the lowest level of these were 
found in 5-Aza-dC only treated group 3, in accord with the previous results that TSA 
promoted hepatic differentiation and 5-Aza-dC failed to improve hepatic 
differentiation potential.  
5.4.2 Macromolecular changes identified by FTIR microspectroscopy 
In an attempt to monitor the cell response to 5-Aza-dC and TSA using FTIR 
mocrospectroscopy, the spectra from each group at each step was analyzed. The 
average FTIR absorbance spectra proved difficult to observe spectral differences 
among each group, so the second derivative spectrum was performed, which gives a 
minimum peak for vibration bands and allows easier identification of individual peaks 
that may be superimposed in the raw spectra. Assignment of biological bands for the 
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IR spectrum was showed in Table 4.2. 
5.4.2.1 Cellular responses monitoring by FTIR microspectroscopy     
during induction step 
5-Aza-dC was added to the pretreatment medium of group 1, 2 and 
3 in order to determine their effect on hepatic differentiation of rBM-MSCs. The 
spectra were collected at the induction step of rBM-MSCs differentiation to 
hepatocyte. The results demonstrated significant spectral differences between 
5-Aza-dC treated cells (G1, 2 and 3) and untreated cells (G4, 5 and 6) (Fig 5.6). The 
cis double bond C=C at 3010 cm-1 associated with unsaturated fatty acids (Guillen 
and Cabo, 1997) was shown to have lower relative absorbance intensity in 5-Aza-dC 
treated cells (G1, 2 and 3) than untreated cells (G4, 5 and 6) (Fig 5.6a). Moreover, the 
bands location at 2958 cm-1 (νasCH3), 2923 cm-1 (νasCH2), 2852 cm-1 (νsCH2) which 
associated with long chain fatty acid of lipid (Socrates, 2001) and the main lipid head 
group (νsC=O stretching at 1743 cm-1) (Guillen and Cabo, 1997) were found to have 
lower content in 5-Aza-dC treated cells. Bands attributed to proteins (1700-1350 cm-1) 
showed more subtle variation differences between the 5-Aza-dC treated and untreated 
cells, only the band at 1627 cm-1 which assigned to intramolccular β-sheet (Bocker et 
al., 2007) was observed to absent in 5-Aza-dC treated cells (Fig 5.6b). The 
DNA/RNA regions (1085 cm-1 assigned to νsPO2-) (Bocker et al., 2007) showed 
higher intensity in 5-Aza-dC treated cells (Fig 5.6c). The integrated area of C=C 
unsaturated fatty acids, CH3 lipid and C=O lipid head were less intense in 5-Aza-dC 
treated cells comparing with untreated cells, whilst, the integrated area of DNA/RNA 
was more intense in 5-Aza-dC treated cells comparing with untreated cells. The 
spectra profiles of protein were shown to be different between 5-Aza-dC treated cells 
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and 5-Aza-dC treated cells, but not significantly different in their content, indicating 
the different protein species were expressed. The results indicated that 5-Aza-dC 
affected the lipid and DNA/RNA content but not the protein content of the cells. 
The PCA model was used to examine the variability of all FTIR 
spectra data set acquired from the 5-Aza-dC treated cells (G1, 2 and 3) and untreated 
cells (G4, 5and 6). Distinct clustering of spectra from 5-Aza-dC treated cells and 
untreated cells were observed in the PCA scores plot along PC2 (explaining 34% total 
variance, Fig 5.7a). The correlation loading plot was shown in Fig. 5.7b. Lipid bands 
at 3010 cm-1 (cisC=C stretch), 2923 cm-1 (νasCH2), 2852 cm-1 (νsCH2), 1740 cm-1 (νs 
C=O stretch) and proteins at 1621 cm-1 (intramolccular β-sheet), were strongly 
negative correlated with 5-Aza-dC untreated cells, indicating that higher intensity of 
these bands in 5-Aza-dC untreated cells, corroborating the difference in relative 
absorbance observed in the average spectra. Other bands associated with proteins 
(α-helix at 1656 cm-1 and intermolecular β-sheet at 1639 cm-1, positive loading) and 
nucleic acid (νsPO2- at 1085 cm-1, positive loading) which were highly positive 
correlated with PC2 were important marker bands for 5-Aza-dC treated cells, 
confirming the results observed in the second derivative spectra. 
5.4.2.2 Cellular responses monitoring by FTIR microspectroscopy 
during differentiation step 
At the differentiation step of rBM-MSCs differentiation to 
hepatocyte, TSA were added to the medium and the spectra were collected from each 
experimental group upon exposure with the separation or combination of 5-Aza-dC 
and TSA. In general, the bands of cis double bond C=C (3010 cm-1), CH3 lipid 
(300-2800 cm-1), νsC=O stretching (1740 cm-1) and amide I (1700-1600 cm-1) were 
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increased and DNA/RNA (1100-950 cm-1) were decreased during differentiation in all 
experimental groups. The integrated area of cis double bond C=C of unsaturated fatty 
acids band were observed significantly lower in 5-Aza-dC treated cells (G1, G2 and 3) 
than that of the control cells (G6) (Fig. 5.6a). Even though, the cells in group 1 were 
further treated with TSA at the differentiation step, there was no significant difference 
in the integrated area of this band between 5-Aza-dC only treated cells (G2 and 3) and 
the cells that combine with 5-Aza-dC and TSA were treated (G1). There was no 
significant difference in the integrated area of this band between TSA only treated 
cells (G4) and control cells. The intensity of lipid bands at 2958 cm-1 (νasCH3), 2923 
cm-1(νasCH2) and 2852 cm-1(νsCH2) were significantly lower in 5-Aza-dC and/or 
TSA treated cells (G1, 2, 3 and 4) compared with the control cells (G6) (Fig 5.6a). 
The band at 1743 cm-1 assigned to νsC=O stretching mainly associated with lipid head 
group was more intense in 5-Aza-dC and/or TSA treated cells (G1, 2, 3 and 4) than 
the control cells (Fig 5.6b). Interestingly, the band at 1722 cm-1 corresponding to the 
C=O stretching of ester group of α and β unsaturated acids (Nara et al., 2002) was not 
observed in 5-Aza-dC or/and TSA treated cells (Group 1, 2, 3, and 4) but in control 
cells. The integrated area of amide I was observed significantly higher levels in 
5-Aza-dC only and a combination with TSA treated cells (G 1 and 3) than that of the 
control cells. More specifically, the predominate components of amide I attribute to 
these differently than those that were located at 1695 cm-1 (aggregated β-sheet), 1681 
cm-1 (β-turn), 1652 cm-1 (α-helix), 1639 cm-1 (antiparallel β-sheet) and 1627 cm-1 
(antiparallel β-sheet) (Bocker et al., 2007). The integrated area of DNA/RNA which 
was centered at 1085 cm-1 (νsPO2-) and 970 cm-1 (RNA ribose phosphate main chain) 
(Wood et al., 2000) showed high intense in 5-Aza-dC or/and TSA treated cells (G 1, 2, 
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3, and 4). It is interesting to mention that the spectra profile and content of 
unsaturated fatty acid in TSA treated cells (G4) were similar to that of control group 
(G6), however, the spectra profile and content of fatty acid, protein and DNA/RNA 
were similar to that of 5-Aza-dC treated cells (G1, 2 and 3). 
The PCA score showed that the spectra extracted from 5-Aza-dC 
and/or TSA treated cells (G1, 2, 3 and 4) and untreated cells (G5 and 6), clustered 
separately along PC1, which explained 67% variance (Fig 5.7 c). The PC1 loading 
plot (Fig 5.7 d) showed that lipid band at 3010 cm-1 (cisC=C stretch), 2958 cm-1(νas 
CH3), 2923 cm-1 (νasCH2), 2852 cm-1 (νsCH2), 1722 cm-1 (C=O stretch) and protein 
band at 1685 cm-1 (β-turn), which were highly negative correlated with PC1 
correlated with untreated cells. Other bands associated with lipid at 1743 cm-1 (νsC=O 
stretching), proteins at 1695 cm-1 (β-sheet), 1656 cm-1 (α-helix) and nucleic acid at 
1085 cm-1 (νsPO2-) and 970 cm-1 (RNA ribose phosphate main chain), which were 
positive loading in PC1 correlated with 5-Aza-dC and/or TSA treated cells. The PC 
results indicated that the spectra profile was similar in 5-Aza-dC and/or TSA treated 
cells at the differentiation step. 
5.4.2.3 Cellular responses monitoring by FTIR microspectroscopy 
during maturation step 
At the maturation step, TSA was further added to the hepatogenic 
medium. The spectra of each experimental group were collected at the end of 
rBM-MSCs differentiation to hepatocyte. The spectra of CH3 lipid (300-2800 cm-1) 
and amide I (1700-1600 cm-1) were increased, in addition, νsC=O stretching (1740 
cm-1) and DNA/RNA (1100-950 cm-1) were decreased during hepatogenic in all 
experimental groups. Fig 5.6 a showed that the integrated area of the cis double bond 
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C=C (3010 cm-1) was not significantly different between treated cells (G1, 2, 4 and 5) 
and the control cells (G6), except 5-Aza-dC only treated cells (G3) which were found 
significantly lower of this band. The intensity of lipid bands at 2958 cm-1(νasCH3), 
2923 cm-1(νasCH2) and 2852 cm-1(νsCH2) were found significantly lower in 
5-Aza-dC only treated cells (G3) than the control cell. Meanwhile, TSA only (G4 and 
5) or a combination with 5-Aza-dC treated cells (G1 and 2) were found to be lower 
than the control group but significantly higher than 5-Aza-dC only treated cells (G3) 
of these bands. The intensity of the main lipid head group (νsC=O stretching at 1743 
cm-1) was significantly higher in TSA only treated cells (G4) than the control cells. 
5-Aza-dC only treated cells (G3) showed the lowest content of this band. The band at 
1722 cm-1 corresponding to the C=O stretching of ester group of α and β unsaturated 
acids appeared in all treated cells except 5-Aza-dC only treated cells. In the protein 
amide I region, the main component at 1695 cm-1 (aggregated β-sheet), 1681 cm-1 
(antiparallel β-turn), 1652 cm-1 (α-helix), 1639 cm-1 (antiparallel β-sheet) and 1627 
cm-1 (antiparallel β-sheet) were significantly higher in 5-Aza-dC only treated cells 
than control cells. There was no significant difference among the other treated cells 
(G1, 2, 4 and 5) of these bands they but showed higher intensity than the control cells. 
In DNA/RNA (1300-900 cm-1), the bands at 1085 cm-1 (νsPO2-) and 970 cm-1 (RNA 
ribose phosphate main chain) were observed to be significantly higher in 5-Aza-dC 
only treated cells than control cells. There was no significant difference in TSA only 
or a combination with 5-Aza-dC treated cells of these bands. 
The PCA scores plot (Fig 5.7e) shows that the spectra extracted 
from 5-Aza-dC only treated cells (G3) and from other treated cells (G1, 2, 4, 5 and 6), 
clustered separately alone PC1 (explained 84% variance). The major peaks for 
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identifying the 5-Aza-dC only treated cells were protein band at 1654 cm-1 (α-helix) 
with other bands at 1085 cm-1 (νsPO2-) and 970 cm-1 (RNA ribose phosphate main 
chain) which associated with nuclei acid (Fig 5.7f), indicating that high intensity of 
these bands in 5-Aza-dC only treated cells at the maturation step. The negative PC1 
loading plot belonging to group1, 2, 4, 5 and 6 shows higher levels in lipid bands at 
3010 cm-1 (cisC=C stretch), 2921 cm-1(νasCH2), 2852 cm-1(νsCH2) and 1722 cm-1 
(C=O stretch) than that of group 3, corroborating the large difference of profile in 
second derivative spectra. 
 
5.5 Discussions 
The objective of this study was to determine the effect of 5-Aza-dC and TSA 
separately or in combination on the rBM-MSCs differentiation to hepatocyte. In 
addition, we proposed to use FTIR microspectroscopy to obtain very specific 
information regarding the biochemical composition and changes in response of the 
cells upon 5-Aza-dC and/or TSA exposure during hepatogenesis. Results of 
conventional techniques showed that 1 μM TSA could improve and enhance the 
hepatic differentiation when it was added at both the differentiation and the 
maturation steps (G4). Especially, TSA found to induce early hepatocyte-like cells 
apparent, increased, prolonged and stabilized the overall expression level of typical 
hepatic protein and enhance hepatic function, such as albumin and urea secretion, 
glycogen production and ICG uptake. However, the degree of improvement is time 
dependent. When the cells were exposured of TSA at the maturation step (G5) neither 
improvement of the hepatic maturation degree, nor hepatic functionality. Our results 
were consistent with a previous study reported by Snykers and colleagues (2007a). 
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Addition of TSA to cultured human bone marrow MSCs, pre-treated for 6 days with 
hepatogenic stimulating agents, triggers their ‘trans’ differentiation into cells with 
similar phenotypic and functional characteristics as primary hepatocytes. Similar 
results have showed that rat bone marrow derived mesenchymal progenitor cells 
(rMPCs) that were exposed to TSA from day 6 of hepatic differentiation onwards. 
Significant hepatic differentiation was found. TSA seems a potential to overcome cell 
fate determinism, cross lineage borders and favor lineage-specific differentiation 
(Snykers et al., 2009). TSA that was added to the stimulating condition failed to 
promote oligodendrocyte differentiation in rat neural progenitors, while it could 
trigger differentiation into neural cells in a neural stimulating condition, which 
indicated that timing is one of the important factors that affect the TSA function 
(Hsieh et al., 2004). Our results showed that exposure TSA only at the maturation step 
failed to promote hepatic differentiation. This may be because of incorrect exposure 
time. Although mechanistic insights in how TSA regulate transcription of 
lineage-specific genes are, at present, largely unresolved, previous studies including 
our results demonstrated that pre-stimulation of the cells towards the intended 
selected direction prior to introduction of TSA, may comprise a key determinate to 
cross lineage boundaries and achieve promoted transdifferentiation into a specific 
lineage by means of TSA inhibition. 
We also found that 5-Aza-dC exposure only failed to improve hepatic 
differentiation potential (G3) with the evidence that lower hepatic maturation degree 
and functionality, which opposite to the previously studies that 5-Aza-dC function as 
preconditioning agents prior to hepatic differentiation (Yamazaki et al. 2003; Aurich 
et al. 2007; Sgodda et al., 2007; Yoshida et al., 2007; Stock et al., 2008). In addition, 
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TSA more or less compensated the function of 5-Aza-dC treatment (G1 and 2) with 
time independent, the improvement of hepatic maturation degree and  hepatic 
functionality were found, indicating that the synergetic or synergistic behavior of 
5-Aza-dC and TSA respect to hepatic differentiation processes (Rogiers et al. 2008). 
The reasons underlying these controversial results are unknown. However, it might be 
due to the different sources of MSCs and difference in microenvironment. Successful 
cell fate manipulation highly relies on the microenvironment (cell-cell contact, cell 
densities), the appropriate type of epigenetic modifier and optimal fine-tuning of its 
dose and timing- onset and duration- of exposure (Shen et al., 2005; Seo-Gutierrez et 
al., 2005; Snykers et al., 2007b; De Kock et al., 2008). The suitability of HDACi 
and/or DNMTi to promote hepatic (trans) differentiation requires a delicate balance 
between proliferation and differentiation, biological activity, pharmacokinetic 
properties and toxicological characteristics, and finally apoptosis and cell survival 
(Snykers et al., 2007b). At least in some cases, failure of lineage-specific 
differentiation could be ascribed to inaccurate timing of exposure and dosage of 
chromatin modulating agents. Basically, although not generally, pre-stimulation of the 
cells towards the intended selected direction prior to introduction of HDACi, may 
comprise a key determinant to cross lineage boundaries and achieve promoted 
transdifferentiation into a specific lineage by means of HDAC inhibition (Enright et 
al., 2005; Kawamura et al., 2005; Seo-Gutierrez et al., 2005; Soto-Gutierrez et al., 
2006; Snykers et al., 2007a; De Kock et al., 2008; Hay et al., 2008; Mizumoto et al., 
2008). 
We further investigated the biochemical changes upon 5-Aza-dC and/or TSA 
exposure by using FTIR microspectroscopy. Exposure TSA at both the differentiation 
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and the maturation step (G4), in general, the changes of spectra profile were similar to 
the control groups, but the level of changes were found to different. The expression 
pathway of cis double bond C=C (3010 cm-1) was found similar to control group (G6), 
however, C=O stretching of ester group of α and β unsaturated acids, CH3 lipid of 
fatty acid, protein amide I secondary structure and DNA/RNA were showed 
significant different. C=O stretching of ester group of α and β unsaturated acids was 
found higher intensity in group 4 than control group (G6) indicated the accumulation 
of unsaturated fatty acids in the cells. Unsaturated fatty acids protect normal cells 
against the damage induced by saturated fatty acids, since the excess fatty acids are 
toxic to cells (Listenberger et al., 2003). Therefore, the unsaturated fatty acid in 
hepatocyte may play a key role on lipotoxicity prevention (Walker, 2004). This result 
confirmed that TSA enhance the hepatocyte function which has been showed in 
conventional testing. The lower intensity of lipid bands at 2958 cm-1 (νasCH3), 2923 
cm-1 (νasCH2) and 2852 cm-1 (νsCH2) were found in group 4 compared with control 
group (G6) at the end of the hepatic differentiation, which is relative to the function of 
the cell. The functional hepatocytes have the ability not only to accumulate 
triglycerides by carbohydrates metabolism but also to oxidize fatty acids produced by 
the cells (Dentin et al., 2006). The possible reason that the lower intensity of lipid 
may be because fatty acids produced by cells being oxidized rather than those 
accumulated in the cell as triglycerides, which further confirms the conventional text. 
We observed the changes of protein secondary structure of the cells, which was 
observed significantly higher in group 4 than control group. This indicates the 
changes in protein composition of the TSA treated cells. The conventional method 
indicated that the different levels of liver specific protein were expressed in TSA 
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treated cells, which result in the protein content being different as shown in the IR 
spectra. The higher intensity of DNA/RNA bands at 1085 cm-1 and 970 cm-1 in TSA 
treated cells than control group (G6) were observed. The possible reason may be that 
TSA induces a hyperacetylation state of chromosome which enhances gene expression 
(Snyker et al., 2009). Furthermore, after exposing TSA to the maturation step (G5), 
the lipid and C=O stretching bands were found to have subtle difference to group 4, 
which reflect the different degree of functional hepatocyte, conforming the result that 
the TSA exposure is time dependent. 
In 5-Aza-dC only treated cells (G3), the changes of spectral profile in lipid, 
protein and the DNA/RNA region were found to have a large difference compared 
with the control group. In 5-Aza-dC only treated cells, the lower intensity of band at 
3010 cm-1 and 1743 cm-1 associated with unsaturated fatty acids indicated a low 
intensity of unsaturated fatty acids, confirming the results that 5-Aza-dC only treated 
fail to induce the functional hepatocyte differentiation. The content of bands at 2958 
cm-1 (νasCH3), 2923 cm-1 (νasCH2) and 2852 cm-1 (νsCH2) were significantly lower in 
5-Aza-dC only treated cells, suggesting low lipid content in the cells. This spectral 
feature also demonstrated that 5-Aza-dC only fail to function hepatocyte 
differentiation, which consisted with the conventional characterization results. The 
confirmed evidence also seem absent of band at 1722 cm-1 which have been defined 
as a marker band in chapter 4. The high level of protein region maybe attributes the 
large proportion of undifferentiated rBM-MSCs which are rich in protein content 
(Blondheim et al, 2006). In addition, 5-Azac-dC have been shown to unmethylated 
DNA and active transcription (Sfzy, 2005), this may be the possible reason that the 
higher intensity of DNA (at 1240 cm-1 and 1085 cm-1) content was observed in 
133 
5-Azac-dC treated cells. Combined exposure 5-Aza-dC and TSA (G1 and 2), 
regardless TSA exposure time, the spectral profile were similar to the control group 
but different to that of 5-Aza-dC or TSA only treated group. The results confirm the 
conventional analysis. 
 
5.6 Conclusion 
The results of conventional biochemistry tests suggesting that 1 μM TSA 
enhance the improvement of hepatic differentiation. On the other hand, exposure with 
5-Azac-dC only or combined exposure of 5-Azac-dC and TSA failed to improve 
hepatic differentiation. The changes in the observed FTIR absorbance bands upon 
5-Azac-dC and TSA treated attributed to lipid, protein secondary structure and 
DNA/RNA. The observation of these biochemical changes contributed to the 
understanding of cell responded to chromatin remodeling agent. FTIR 
microspectroscopy are shown to be useful tools for tracking the alteration of 
biochemical molecular in cells during exposed to chromatin remodeling agent. 
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 Figure 5.1  Changes in cell morphology during hepatic differentiation of rBM-MSCs. 
The cells in Group 1 (a-d), Group 2 (e-h), Group 3 (i-l), Gropu 4 (m-p), 
Group 5 (q-t) and Group 6 (u-x) exhibited fibroblast like morphology at 
the conditioning stage (a, e, i, m. q and u), small round or oval 
morphology at the induction stage (b, f, j, n, r and v), islands 
morphology at the differentiation stage (c, g, k, o, s and w) and 
hepatocyte like morphology at the maturation stage (d, h, l, p, t and x), 
respectively. Original magnification, 40 ×. 
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 Figure 5.2  The expression of HNF 3β, AFP, CK18, HNF 1α, ALB and C/EBPα at 
the last day of hepatic differentiation of each experimental group by 
immonocytochemistry. The first row from the top to the sixth at the 
bottom represents Group1 to Group 6, respectively. Original 
magnification, 200 ×. 
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 Figure 5.3  Comparative of hepatocyte specific proteins expression upon chromatin 
remodeling agent exposure. Immunocytochemistry was performed for 
HNF 3β (a), AFP (b), CK18 (c), ALB (d), HNF 1α (e), C/EBPα (f). 
Values represent means ± SD. Significance was set at P< 0.05. 
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Figure 5.4  RT-PCR analyses of the temporal expression pattern of selected 
hepatocyte specific gene during hepatic differentiation of rBM-MSCs. 
AFP, HNF 3β, ALB and CYP2B1 expression were analyzed at the 
induction step (a), the differentiation step (b) and maturation step (c), 
respectively. 
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 Figure 5.6  Average second derivative FTIR spectra of rBM-MSCs differentiation 
into hepatocyte-like cell upon exposure of chromatin remodeling agent at 
different stages. (a) Shows an enlargement of the lipid region 
(3000-2800 cm-1); (b) shows an enlargement of the protein region 
(1760-1350 cm-1); (c) shows an enlargement of nucleic acid region (1350 
-900 cm-1). Significance was set at P< 0.05. 
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 Figure 5.7  PCA scores plots (a, c and e) and loading plot (b, d and f) of rBM-MSCs 
differentiation into hepatocytes upon exposure of chromatin remodeling 
agent at difference stages. Spectra were process to the 2nd derivative over 
the spectral range between 3000-2800 cm-1 and 1800-800 cm-1.
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CHAPTER VI 
THERAPEUTIC EFFECT OF BONE MARROW 
DERIVED MESENCHYMAL STEM CELLS ON 
EXPERIMENTAL LIVER DAMAGE AND 
INVESTIGATION BY SYNCHROTRON FTIR 
MICROSPECTROSCOPY 
 
6.1 Abstract 
The transplantation of autologous bone marrow-derived mesenchymal stem 
cells (BM-MSCs) holds great potential for treating end-stage liver diseases. 
Multipotent BM-MSCs can differentiation into hepatocytes, but few reports addressed 
to direct comparison of relative efficiency transplant of BM-MSCs and BM-MSCs 
derived hepatocyte. The aim of this study was to compare the efficiency of rat 
BM-MSCs (rBM-MSCs) line with that of its hepatogenic differentiation derivative for 
suppression of dimethylnitrosamine-injured liver diseases rats, whilst, synchrotron 
radiation Fourier transform infrared (SR-FTIR) microspetroscopy was applied to 
investigate the biochemical molecular alteration of the liver tissue after 
transplantation of cells. Transplantation of the rBM-MSCs derived hepatocytes into 
liver-injured rats restored their serum albumin level and significantly suppressed 
transaminase activity and liver disease. In contrast, these effects were not observed in 
the transplantation of rBM-MSCs. The changes of average spectra located near 
1190-970 cm-1 (1150 cm-1, 1081 cm-1and 1026 cm-1) indicated deceased levels of 
glycogen and other carbohydrate, in rBM-MSCs derived hepatocytes treated liver 
compared with control group and rBM-MSCs treated liver. Principal component 
analysis (PCA) could distinguish rBM-MSCs derived hepatocytes treated liver and 
control group or rBM-MSCs treated liver. We conclude that the transplantation of 
rBM-MSCs derived hepatocytes effectively treats liver disease in rat and SR-FTIR 
microspetroscopy provides important insights into the fundamental biochemical 
alteration occurring during stem cells transplantation.  
 
6.2 Introduction 
Liver damage often leads to liver fibrosis and sometimes leads to subsequent 
liver cirrhosis. Liver transplantation is one of the most effective treatments for severe 
liver-associated diseases such as cirrhosis. However, due to the shortage in donated 
organs and the growing list of patients in need of such intervention, transplantation is 
often not common (Iredale et al. 2003). Current studies suggest that hepatocyte 
transplantation may develop into a feasible alternative to whole-organ transplantation, 
however, the efficiency of isolation of sufficient transplantable hepatocytes is very 
low and is restricted by the small number of marginal donor organs allocated for this 
purpose (Lagasse et al., 2000; Thorgeirsson et al., 2006; Jiang et al., 2002; Reyes et 
al., 2002). Hence, novel cell sources are required to deliver hepatocytes of adequate 
quality for clinical use. Most of the recent studies concentrate on stem cells of 
extrahepatic origin, because of their ready availability and unrestricted potential to 
propagate and differentiate. 
The preeminent candidate stem cells for therapy of an injured liver are 
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mesenchymal stem cells (MSCs), which possess both multipotentiality and 
semi-infinite proliferation ability. MSCs in vitro have the potential to differentiate into 
hepatocytes (Lee et al. 2004; Schwartz et al. 2002). Moreover, studies have shown 
that rat or human mesenchymal stem cells can differentiate into hepatocyte-like cells 
when transplanted into rat liver (Baksh et al. 2004; Li et al. 2006; Zhan et al. 2006). 
Recently, transplantation of rat bone marrow mesenchymal stem cells has been shown 
to protect the rat liver from chemically induced liver fibrosis (Zhao et al. 2005). Oyagi 
et al. provided evidence that transplantation of bone marrow-derived mesenchymal 
cells cultured with HGF, but not those without HGF, improved some hepatic functions 
and suppressed liver fibrosis in rats injured by CCl4 (Oyagi et al., 2006). Several other 
studies have shown that transplantation of bone marrow-derived mesenchymal stem 
cells could ameliorate liver fibrosis (Fang et al., 2004; Zhao et al., 2005), but their 
effects were marginal or characterization of the cells used was limited. Thus, it 
remains controversial which type(s) of cells among those derived from the bone 
marrow shows the most potent suppressive effect on fibrosis, although further 
evidence that bone marrow cells contribute to regression of liver fibrosis in mice has 
recently been provided (Higashiyama et al., 2007; Ishikawa et al., 2007). 
FTIR microspectroscopy is a powerful technique, which has been widely 
used in biophysical research, proven to provide sensitive and precise measurement of 
biochemical changes in biological cells and tissue (Lasch and Boese, 2001). Recently, 
synchroyton infrared microspectroscopy has been used for the early detection of live 
fibrosis (Liu et al., 2006). FTIR imaging analysis could become a valuable analytic 
method in brain tumor research and possibly in the diagnosis of human brain tumors 
(Bambery et al., 2006). Wang et al used FTIR microspectroscopy to study the 
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compositional changes in inflammatory cardiomyopathy and the results demonstrate 
chemical difference between the inflammatory responses in mouse model, providing 
insight into why the disease can be self-limiting in some cases while fatal in others 
(Wang et al., 2005). This approach provides structural information of biological 
molecules such as protein, nucleic acids, carbohydrates and lipids, allowing detection, 
identification and quantification of changes in these macromolecular cellular 
components. 
This study, we aimed to compare the efficiency of rat BM-MSCs line with 
that of its hepatogenic differentiation derivative for suppression of 
dimethylnitrosamine injure liver diseases rats, whilst, synchrotron radiation Fourier 
transform infrared (SR-FTIR) microspetroscopy was applied to investigate the 
biochemical molecular alteration of the liver tissue after transplantation of cells. 
 
6.3 Materials and methods 
6.3.1 Preparation of cells 
rBM-MSCs were isolated and cultured implemented employing the same 
protocol as chapter 3. rBM-MSCs were maintained in the same culture medium as 
chapter 3. For inducing differentiation of hepatogenic lineage, rBM-MSC were 
explored to conditioning medium containing IMDM, 10 ng/ml bFGF and 20 ng/ml 
EGF for 2 days; following differentiation medium consisting of IMDM, 20 ng/ml 
HGF, 10 ng/ml bFGF and 4.9 mmol/L nicotinamide for 7 days and differentiation and 
maturation medium consisting of IMDM, 10 μmol/ml ITS, 1μmol/ml Dex, and 20 
ng/ml OSM for 14 days.  
6.3.2 Treatment of animals 
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Female Wistar rats were 3 weeks old, weighing between 180 and 200 g. 
Rats were bred and maintained in an air conditioned animal house with specific 
pathogen-free conditions, and were subjected to a 12:12-hours daylight/darkness and 
allowed unlimited access to chow and water. Liver damage was induced by 
dimethylnitrosamine (DMN) administration as follow: On day 0, rats were injected 
intraperitoneally at a dose of 100 μL DMN (diluted 1:100 with 0.15 mol/L sterile 
saline) per 100 g body weight. The injection was given on three consecutive days of 
each week for 4 weeks. 
6.3.3 Transplantation experiments 
After being detached from the plate by trypsin/EDTA treatment, the cells 
were stained using the PKH Fluorescent Cell Linker kit. Cells were suspension in l ml 
phosphate buffer saline for each donor cells at the concentration of 1×106 cells/ml. 
Nine rats were randomly divided into three groups after 4 weeks DMN-induced: 
DMN/rBM-MSCs, n = 3, to inject intravenously a dose of rBM-MSCs 1×106 cells per 
rat; DMN/hepatocyte, n = 3, to inject intravenously a dose of hepatocytes 1×106 cells 
per rat; DMN/saline, n = 3, to inject the same volume of saline. On day 28, venous 
blood was collected and all rats were killed, and liver tissue harvested for analysis. 
Animal studies were carried out in compliance with the guidelines of the Institute for 
Laboratory Animal Reaesrch, Suranaree University of Technology. 
6.3.4 Histopathologic staining 
Frozen liver samples (approx. 0.5 cm3) were randomly taken from the right, 
median and left lobes of each rat liver and embedded in optimal temperature cutting 
(OCT) compound, sectioned consecutively at 10 μm in a cryostat at -18 °C. The liver 
section were mounted on slides for histopathologic staining and fluorescence 
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detection and also plated on MirrIR low-e infrared reflective slides for FTIR analysis. 
PKH26 derived fluorescence was observed using fluorescence microscope, and 
number of positive cells were counted in more than three different views for each 
liver sample. For Hematoxylin and Eosin staining (H&E), the liver sections were 
mounted on slides and air dried for at least 20 minutes followed by fixation in 10% 
Formalin for 30 seconds. Then these sections were stained with routine H&E 
according to regular staining procedure such as hydration, staining, dehydration and 
clearing. The stained slides were finally covered with a cover-slip using a mounting 
medium Entellen.  
6.3.5 Assessment of liver function 
Blood sample were obtained from each rat and centrifuged for 30 minutes 
at 600 ×g and serum was collected. Albumin (ALB), aspartate aminotrsnsferase (AST) 
and alanine transaminase (ALT) were assessed using conventional laboratory 
methods.  
6.3.6 Synchrotron infrared microspectroscopy (SR-FTIR) 
High spatial resolution infrared spectral maps were collected at an infrared 
microspectroscopy beamline (2BM1B) at the Australian Synchrotron, Melbourne, 
Australia. SR-FTIR spectra were acquired using a Hyperion 2000 FTIR microscope 
(Bruker Optik GmbH, Ettlingen, Germany) with a narrow-band mercury cadmium 
telluride (MCT) detector coupled to a Bruker Vertex 80V FTIR spectrometer, which 
was connected to IR beamline at the Australian Synchrotron. The sample was mapped 
through the focused beam using a X-Y step size of 4 μm with a 4 μm aperture in the 
microscope focal plane with a spectral resolution of 8 cm−1 with 64 interferograms 
coadded. All acquisition and control functions of the microscope were performed 
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though Bruker Opus version 6.5.  
6.3.7 Data analysis 
Spectra from all liver samples were extracted using CytoSpecTM (Cytospec 
Inc., Boston MA, USA) spectroscopic software after performing a quality test to 
assess the appropriate sample thickness, rejecting spectra with maximum absorbance 
less than 0.2 or greater than 0.8 absorbance units over the spectrum range of 3100-970 
cm-1. Spectra extracted using Cytospec were subsequently converted into galactic 
format by a macro converter in OPUS6.5 software in preparation for multivariate data 
analysis. 
Representative spectra from all groups were processed and compared 
following multivariate analysis. Prior to multivariate analyses or classification the 
data was preprocessed by performing second derivative using the Savitzky-Golay 
algorithm with 9 smoothing points, and normalization using Extended Multiplicative 
Signal Correction (EMSC). The Unscrambler 9.7 software was used for multivariate 
data analysis. 
 
6.4 Results 
6.4.1 The liver-damaged rat model 
Routine H&E staining was employed to characterize representative liver 
sections at 1 week, 2 weeks and 4 weeks following DMN injection and the normal 
liver section as control, as displayed in Fig. 6.1. The liver tissue from normal liver 
showed the normal histological cytoplasm of hepatocyte, i.e., they are polyhedral with 
eosinophilic cytoplasm and a usually central nucleus (Fig. 6.1a). However, for 1 week 
following DMN injection, necrosis areas appeared. Specifically, after 2 weeks of 
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DMN injection, the large areas of necrosis were found. At the fourth week of injection, 
the alteration of liver structure was even more evident, with more hemorrhagic 
necrosis and disruption of tissue architecture. 
6.4.2 Tracing of transplanted cells in the DNM-injured liver 
PKH26-stained rBM-MSCs and hepatocytes were transplanted into 
DMN-injured rats to examine what cell type is effective for the engraftment in the 
liver. Fig. 6.2 showed the fluorescence images and the positive engraftment cell 
number. The PKH26-stained cells were easily detected in the liver by fluorescence 
microscopy. The transplanted cells were located in blood vessels, the sinusoid, and the 
liver lobules. This result suggested that the transplanted cells entered sinusoid and 
liver parenchymal tissue. There was significant difference between the positive cell of 
liver that receive an rBM-MSCs derived hepatocyte transplant and that of liver 
receiving rBM-MSCs. Therefore, induction hepatic differentiation pre-transplantation 
was more effective for improving the engraftment of rBM-MSCs to the injured 
recipient liver. 
6.4.3 Recovery of albumin production by stem cells transplantation 
The normal level of rat serum albumin was 3.9 g/dL, while the DMN 
treatment rat serum albumin was 3.2 g/dL, which was significant lower than normal 
level (Fig. 6.3a). Liver-injured rats recovered serum albumin levels but still lower 
than that of normal level following by the transplantation of rBM-MSCs. In contrast, 
the transplantation of rBM-MSCs derived hepatocyte into liver damaged rats restored 
the serum albumin close to the normal level. Although it is not clear whether the 
transplanted rBM-MSCs differentiated into hepatocytes that produced albumin, or 
whether DMN-damaged liver regenerated in response to the rBM-MSCs derived 
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hepatocyes, induction hepatic differentiation pre-transplantation effectively led to 
restored albumin production after the transplantation. 
6.4.4 Suppression of liver inflammation by stem cells transplatation 
The normal AST and ALT levels in serum were 155 and 110 U/L, 
respectively. As shown in Fig. 6.3, the serum AST and ALT levels in the DMN-treated 
rats were 220 and 180 U/L, respectively, which were significantly higher than normal 
level. The transplantation of rBM-MSCs derived hepatocyes significantly suppressed 
the serum AST and ALT levels to the normal in the DNM-injured rats. The 
transplantation of rBM-MSCs suppressed the serum AST and ALT level in the 
DNM-injured rats but still could not suppress to the normal level. Induction hepatic 
differentiation pre-transplantation effectively suppressed liver inflammation.  
The effects of rBM-MSCs and rBM-MSCs derived hepatocyes on 
DMN-injured liver were evaluated by histopathologic examination of the liver 
sections by H&E staining. The control group (Fig. 6.4a), exhibited the hemorrhagic 
necrosis and disruption of tissue architecture. The changes of necrosis areas and the 
tissue architecture in the liver sections were observed in transplantation of 
rBM-MSCs group (Fig 6.4b). These alterations were remarkably changed in 
transplantation of rBM-MSCs derived hepatocyes group. Hemorrhagic necrosis was 
rarely observed and tissue architecture appears to be similar to that of normal rats (Fig 
6.4c). 
6.4.5 Synchrotron radiation Fourier Transform Infrared (SR-FTIR)     
microspetroscopy investigation of liver tissue 
SR-FTIR microspetroscopy was applied to investigate the biochemical 
molecule alteration of the liver tissue after transplantation of rBM-MSCs and 
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rBM-MSCs derived hepatocytes to DMN-injured rats. Fig 6.5 shows average second 
derivative IR spectra from 1800 to 950 cm-1 in each group. The average spectra 
showed difference in bands near 1658 cm-1 (α-helix), 1544 cm-1 (amide II), as well as 
IR absorbance bands at 1150 cm-1, 1081 cm-1, 1026 cm-1 which were assigned to 
glycogen and other carbohydrate (Camacho et al., 2001). The intensities of α-helix 
(1658 cm-1) and amide II (1544 cm-1) shown higher in rBM-MSCs injection liver 
tissue, followed by rBM-MSCs derived hepatocyte injection liver tissue than that in 
normal liver tissue, indicating the different protein content. It was also shown that the 
glycogen and other carbohydrate bands at 1150 cm-1, 1081 cm-1, 1026 cm-1, were 
highest in DMN-injured liver tissue (control), and followed by rBM-MSCs liver tissue 
and rBM-MSCs derived hepatocyte injection liver tissue. The profile of these bands in 
rBM-MSCs derived hepatocyte injection liver tissue shown close to that of normal 
liver tissue. 
PCA analysis of the SR-FTIR spectra was performed in the 1770-1500 cm-1 
and 1190-970 cm-1 spectral region. The PCA score plot showed that the spectra 
extracted from control group, rBM-MSCs injection group, rBM-MSCs derived 
hepatocyte injected group and normal liver can be clustered separately along PC1 
(69%) and PC2 (19%) (Fig 6.6a). Spectra from control liver tissue and rBM-MSCs 
injection liver tissue could be could be distinguished from rBM-MSCs derived 
hepatocyte injected liver tissue and normal liver tissue by having negative loading at 
1666 cm-1, 1157 cm-1, 1083 cm-1 and 1027 cm-1 attributed to protein secondary 
structure and glycogen and other carbohydrate, in line with the average secondary 
spectra (Fig 6.6b). Spectra from control liver tissue could be separated from 
rBM-MSCs injected liver tissue by having negative loading at 1666 cm-1, 1157 cm-1, 
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1083 cm-1 and 1027 cm-1, showing the higher content of these bands in control liver 
tissue. These PC result showed that difference in bands associated with collagen were 
responsible for the separation of the clusters of the each group. 
 
6.5 Discussion 
In this study we showed the effectiveness of transplanting rBM-MSCs to 
treat liver failure in an experimental animal model, which consistent with previous 
study (Oyagi et al., 2006). Induction hepatic differentiation pre-transplantation 
enhanced the engraftment of rBM-MSCs in the recipient liver and caused clear 
therapeutic effects in DMN-injured rats. We found that the transplantation of 
rBM-MSCs derived hepatocyes significantly reduced the serum transaminase levels in 
DMN-injured rats. Induction hepatic differentiation pre-transplantation appeared to be 
effective for the suppression of liver inflammation. PKH staining showed that a 
significantly higher number of rBM-MSCs derived hepatocyes were engrafted in 
injured liver than rBM-MSCs. These rBM-MSCs derived hepatocyes which induced 
by hepatocyte growth factor (HGF) showed higher engraftment potential. Previous 
reported that HGF up-regulated C-X-C chemokine receptor type 4 (CXCR4), which is 
the chemokine receptor for stromal cell-derived factor-1 (SDF-1), in human 
hematopoietic stem cells (Horuk, 2001; Kollet et al., 2003). The SDF-1 is expressed 
in liver bile duct epithelium and the secretion is increased by the inflammation. The 
CXCR4 might be up-regulated in rBM-MSCs derived hepatocyes which induced by 
HGF and the engraftment in the injured liver could be enhanced by the interaction 
with SDF-1. The report has shown that CCl4-injured hepatocytes stimulated HGF 
secretion in the co-cultured BM-MSCs (Oyagi et al., 2006). HGF is well known to 
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suppress hepatocyte death and liver fibrosis (Sakaida et al., 2004). When transplanted 
into DMN-injured rat, engrafted rBM-MSCs derived hepatocyes could secrete HGF in 
the liver and suppress the inflammation. However, our result opposite to the previous 
result that undifferentiated rBM-MSCs were the most effective for suppression of 
liver fibrosis (Hardjo et al., 2009). It is still not clear why and how the 
undifferentiated rBM-MSCs most effectively suppressed liver fibrosis. The different 
results of our current study maybe attribute to the different approach of rBM-MSCs 
delivery. In our study, we chose intravenous injection, which is an easy and 
convenient way of stem cells delivery, with less invasive and traumatic (Xu and Liu, 
2008). The reports had shown that intravenous injection of manipulation of the 
transplanted cells more efficient to migrate to the target areas, because the injured 
target organ may express specific receptor or ligands to facilitate trafficking of such 
manipulation transplanted cells (Xu and Liu, 2008). 
We employed SR-FTIR microspetroscopic technique to obtain more insight 
into the biochemical molecule changing after transplantation of rBM-MSCs to the 
DMN-injured rat. The spectra profile of each group has shown significantly different 
in the region of 1770-980 cm-1 which associated with protein secondary structure and 
glycogen and other carbohydrate. The different in protein secondary structure of 
amide I and II indicated the different protein expression in each group. DMN could 
destroy protein and inhibit the protein synthesis as revealed by the lower protein 
absorbance in the control group (Villa-Trevino, 1967). The higher level protein 
absorbance was found in rBM-MSCs and rBM-MSCs derived hepatocyte injection 
group, suggesting the resume of protein synthesis after cells transplantation. However 
the mechanisms of how this transplanted cells resume the protein synthesis still 
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unclear. It was also shown that the absorbance of glycogen and other carbohydrate 
bands observed between 1190-970 cm-1 (1150 cm-1, 1081 cm-1, 1026 cm-1), were 
observed to lower in rBM-MSCs derived hepatocyte treated liver than that in control 
group and rBM-MSCs treated group. Liver plays a major role in carbohydrate 
metabolism. DMN causes liver loses function particularly in destruction of 
glycogenolysis which leads to accumulation of glycogen in the liver. In control group, 
these bands were observed to have the highest level indicated the accumulation of 
glycogen in liver. However, these bands were shown to lower in rBM-MSCs and 
rBM-MSCs derived hepatocyte injection group, especially in rBM-MSCs derived 
hepatocyte injection group, suggesting the decrease of glycogen deposition in the liver, 
which results in resuming the carbohydrate metabolism in the liver after cells 
transplantation. In rBM-MSCs derived hepatocyte injection group, the profile of these 
bands were found to similar to that of normal liver tissue, indicating the same 
biochemical molecular between then, which confirm that rBM-MSCs derived 
hepatocyte effectively treats liver disease.  
 
6.6 Conclusion 
The transplantation of rBM-MSCs derived hepatocyte effectively treats liver 
injury in rats. They restored serum albumin level and significantly suppressed 
transaminase activity and liver disease. This is a promising technique for autologous 
transplantation in humans with liver injury. The changes of average spectra located 
near 1190-970 cm-1 in rBM-MSCs derived hepatocyte treated liver indicated the 
resume of protein synthesis and carbohydrate metabolism in the liver after cells 
transplatation. SR-FTIR microspetroscopy provides biochemical information that is 
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complimentary to that obtained from conventional technique to monitoring stem cell 
transplantation. 
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 Figure 6.1  Representative liver tissues stained with hematoxylin and eosin. Normal 
liver (a); 1 week injection of DMN (b); 2 weeks injection of DNM (c); 4 
weeks injection of DMN (d). Original magnification, 100 ×. 
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Figure 6.2  Engraftment of PKH-stained rBM-MSCs and hepatocyte in DMN 
-injured rat liver. Non-transplanted liver from DMN-treated rats was 
used as the control (a and b). rBM-MSCs (c and d) and hepatocyte (e and 
f) were transplanted into DMN-injured rats, and 4weeks later liver 
sections were observed with fluorescence microscope. The left (a, c and 
e) and right (b, d and f) picture are bright-field and fluorescence image, 
respectively. Positive number of PKH fluorescence (g). Significance was 
set at P< 0.05. Original magnification, 100 ×. 
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 Figure 6.3  Biochemical analysis. Concentration of albumin, AST and ALT in blood 
serum of rat. Significance was set at P< 0.05.   
 
Figure 6.4  Hematoxylin and Eosin staining of liver sections from DNM-injured rats 
that received cell transplant. (a) Saline/DMN; (b) rBM-MSCs/DMN; (c) 
hepatocyte/DMN. Original magnification, 200 ×. 
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 Figure 6.5  Average second derivative FTIR spectra from 1800 to 950 cm-1. 
 
Figure 6.6  PCA scores plots (a) and loding plot (b). Spectra were process to the 2nd 
derivative over the spectral rang between 1770-1500 cm-1 and 1190-970 
cm-1. 
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CHAPTER VII 
OVERALL CONCLUSION 
 
BM-MSCs are a population of self-renewing multipotent cells that have 
significant clinical potential in cellular therapies and tissue regeneration owing to 
their potential ease of in vitro culture and manipulation. The results from this thesis 
have demonstrated that rBM-MSCs could be isolated by selective plastic surface 
attached method and seeded at low initial seeding densities, resulting in higher yields 
and faster expansion. TSA but not 5-Aza-dC is essential to promote differentiation of 
rBM-MSCs towards functional hepatocyte-like cells in vitro. Transplantation of 
rBM-MSCs derived hepatocytes effectively treats liver disease in rat. FTIR 
microspetroscopy together with SR-FTIR microspetroscopy provides a practical tool 
to monitor stem cells differentiation and transplantation based on detecting the unique 
information about the biochemistry and molecular composition of cells and tissue. 
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